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Differential Requirements For Mitochondria During Neuronal Migration
Abstract
During the development of the cortex neurons must migrate from their sites of birth to their final
destinations. There are two main types of migration in the developing cortex, the radial migration of
pyramidal neurons and the non-radial migration of cortical interneurons. There are limited studies directly
comparing these two migration processes, and thus our understanding for perturbations that are
selective to either non-radial versus radial migration is limited. Understanding causes of disruption of
interneuron migration specifically is clinically relevant due to several interneuron specific developmental
diseases. There is a growing body of literature observing a link between interneuron disorders and
mitochondrial dysfunction, and thus regulation of mitochondria and their functions are promising targets
for identifying selective effects on interneuron development. Mitochondria are organelles serving multiple
functions in cells, including energy production, calcium buffering, redox homeostasis, and regulation of
cell death. Although mitochondria are known to play essential roles in maintaining neuronal health and
function in the adult brain, the importance of mitochondria during neuronal development is poorly
understood.
Using in vitro mouse brain explant and slice culture systems, we observed distinct localization patterns of
mitochondria between interneurons and pyramidal neurons. Mitochondria in migrating interneurons move
cyclically throughout the cell during the migration process while remaining in front of the nucleus in
migrating radial neurons. Fluorescence immunohistochemistry confirmed these localization patterns in
embryonic mouse brains in vivo.
We then applied pharmacologic tools to disrupt mitochondrial oxidative phosphorylation and discovered
that interneuron migration is profoundly sensitive to these disruptions compared to radially migrating
pyramidal neurons. This was confirmed by examination of a genetic model of compromised oxidative
phosphorylation (Ant1). Interneurons with compromised mitochondrial function exhibit decreased
migration, increased changes in direction, increased trailing process length, changes in branching
behavior, and shifts in centrosome positioning.
We then utilized a dominant negative form of Miro1, a protein involved in mitochondrial trafficking to alter
mitochondrial trafficking behavior. We also observed increased direction changes and reduced ability of
interneurons to invade the cortex. However, interneuron migration rate was unaffected. The changes in
cell migration behavior suggest that mitochondria play a central role in maintaining interneuron cell
polarity to allow for progressive interneuron migration during their long journey.
These data collectively support a model in which mitochondrial perturbations have a selective effect on
interneuron migration. This work suggests that neuronal deficits occurring in mitochondrial disorders are
not exclusively due to neuronal metabolic insufficiency in postnatal stages, but can also have
developmental origins.
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ABSTRACT

DIFFERENTIAL REQUIREMENTS FOR MITOCHONDRIA DURING
NEURONAL MIGRATION
Erika Lin-Hendel
Stewart Anderson
Jeffrey Golden

During the development of the cortex neurons must migrate from their sites of birth to
their final destinations. There are two main types of migration in the developing cortex, the radial
migration of pyramidal neurons and the non-radial migration of cortical interneurons. There are
limited studies directly comparing these two migration processes, and thus our understanding for
perturbations that are selective to either non-radial versus radial migration is limited.
Understanding causes of disruption of interneuron migration specifically is clinically relevant due
to several interneuron specific developmental diseases. There is a growing body of literature
observing a link between interneuron disorders and mitochondrial dysfunction, and thus
regulation of mitochondria and their functions are promising targets for identifying selective
effects on interneuron development. Mitochondria are organelles serving multiple functions in
cells, including energy production, calcium buffering, redox homeostasis, and regulation of cell
death. Although mitochondria are known to play essential roles in maintaining neuronal health
and function in the adult brain, the importance of mitochondria during neuronal development is
poorly understood.
Using in vitro mouse brain explant and slice culture systems, we observed distinct
localization patterns of mitochondria between interneurons and pyramidal neurons. Mitochondria
in migrating interneurons move cyclically throughout the cell during the migration process while
v

remaining in front of the nucleus in migrating radial neurons. Fluorescence
immunohistochemistry confirmed these localization patterns in embryonic mouse brains in vivo.
We then applied pharmacologic tools to disrupt mitochondrial oxidative phosphorylation
and discovered that interneuron migration is profoundly sensitive to these disruptions compared
to radially migrating pyramidal neurons. This was confirmed by examination of a genetic model
of compromised oxidative phosphorylation (Ant1). Interneurons with compromised
mitochondrial function exhibit decreased migration, increased changes in direction, increased
trailing process length, changes in branching behavior, and shifts in centrosome positioning.
We then utilized a dominant negative form of Miro1, a protein involved in mitochondrial
trafficking to alter mitochondrial trafficking behavior. We also observed increased direction
changes and reduced ability of interneurons to invade the cortex. However, interneuron migration
rate was unaffected. The changes in cell migration behavior suggest that mitochondria play a
central role in maintaining interneuron cell polarity to allow for progressive interneuron migration
during their long journey.
These data collectively support a model in which mitochondrial perturbations have a
selective effect on interneuron migration. This work suggests that neuronal deficits occurring in
mitochondrial disorders are not exclusively due to neuronal metabolic insufficiency in postnatal
stages, but can also have developmental origins.

vi

INTELLECTUAL CONTRIBUTION
The experiment in Chapter 2, figure 7B showing absence of Ant1 expression in mutant mice were
done by Meagan McManus in the lab of Doug Wallace. The confirmation of normal radial
migration in Chapter 2, Figure 10B were done by Erika Lin-Hendel and Ginam Cho in the
laboratories of Stewart Anderson and Jeffrey Golden. The constructs utilized for Chapter 3
experiments, pCAG-IG-Miro1 and pCAG-IG-Miro1K208, were generated by Ginam Cho in the
lab of Jeff Golden.
All other experiments in Chapter 2 and all of the experiments in Chapter 3 and 4 were done by
Erika Lin-Hendel in the laboratories of Jeffrey Golden and Stewart Anderson.
Chapter 2 is published in the journal Cell Reports March 31, 2016 “Differential Mitochondrial
Requirements for Radially and Non-radially Migrating Cortical Neurons: Implications for
Mitochondrial Disorders.” and is available via open access here:
www.cell.com/cell-reports/pdf/S2211-1247(16)30280-7.pdf
At the time of submission data from Chapter 3 and Chapter 4 are unpublished results

vii

TABLE OF CONTENTS

ACKNOWLEDGMENT................................................................................................................ IV
ABSTRACT.................................................................................................................................... V
LIST OF ILLUSTRATIONS ......................................................................................................... IX
CHAPTER 1: GENERAL INTRODUCTION ................................................................................ 1
CHAPTER 2 - DIFFERENTIAL MITOCHONDRIAL REQUIREMENTS FOR RADIALLY
AND NON-RADIALLY MIGRATING CORTICAL NEURONS: IMPLICATIONS FOR
MITOCHONDRIAL DISORDERS............................................................................................... 20
CHAPTER 3: MANIPULATIONS OF THE MITOCHONDRIAL TRAFFICKING PROTEIN
MIRO1 IMPACTS INTERNEURON MIGRATION .................................................................... 49
CHAPTER 4: CONCLUSIONS / FUTURE DIRECTIONS ......................................................... 72
REFERENCES .............................................................................................................................. 96

viii

LIST OF ILLUSTRATIONS
Figure 1. Development of the cortex ............................................................................................... 7
Figure 2. Mitochondrial oxidative phosphorylation ...................................................................... 13
Figure 3. Mitochondrial localization in migrating neurons. .......................................................... 23
Figure 4. Mitochondrial localization in interneurons in vivo ......................................................... 26
Figure 5. Oligomycin treatment of INs impacts migration ............................................................ 29
Figure 6. Pharmacological inhibition of OXPHOS reduces IN migration. .................................... 30
Figure 7. Migrating interneurons express Ant1 ............................................................................. 34
Figure 8. Interneuron migration is reduced in embryonic Ant1 mutants. ...................................... 35
Figure 9. Abnormal migration by Ant1-/- interneurons. ................................................................. 38
Figure 10. Radial migration is normal in Ant1 -/- cortices ............................................................. 40
Figure 11. Loss of Ant1 causes a shift in centrosome position...................................................... 41
Figure 12. Proteins involved in mitochondrial trafficking ............................................................. 51
Figure 13. Miro1 protein is detected in E14.5 striatum ................................................................. 54
Figure 14. pCAG-IG-Miro1K208 expression in 3T3 cells results in perinuclear localization of
mitochondria. ......................................................................................................................... 55
Figure 15. Expression of Miro1K208 increases direction changes in migrating INs in vitro........ 57
Figure 16. Miro1K208 expression reduces invasion of migrating INs into the cortex in slice
culture .................................................................................................................................... 58
Figure 17. Expression of Miro1K208 in migrating interneurons does not cause gross
mitochondrial localization defects. ........................................................................................ 59
Figure 18. Imaging techniques examining mitochondria ............................................................... 61
Figure 19. Miro1K208 has subtle effects on radial migration ....................................................... 63
Figure 20. Bongkrekic acid treated cells exhibit changes in acetylated tubulin and F-actin
localization ............................................................................................................................. 76
Figure 21. Preliminary data reveals profound cortical abnormalities in Ant1/2 DKO within the
mouse cortex. ......................................................................................................................... 91

ix

CHAPTER 1: GENERAL INTRODUCTION
Neurodevelopmental disorders (NDDs) are genetic or acquired diseases that result in
childhood-onset of brain dysfunction. NDDs manifest with a broad spectrum of phenotypes.
When severe enough, these disorders present with conditions that include epilepsy, intellectual
disability (ID) and autism spectrum disorder (ASD). NDDs impose a significant financial and
social toll, in part due to their early onset. Unfortunately, treatment options for these diseases are
limited. Thus understanding the neurobiological basis of these disorders is paramount to identify
new preventative and interventional therapies. Over the past decade, GWAS studies, and more
recently, whole exome and genome studies have elucidated the genetic basis in a number of
clinical patients. From this data, a fascinating common thread is emerging implicating metabolic
dysfunction in many of these disorders. As mitochondria are crucial to cellular metabolism, there
is great interest in understanding the role these organelles play in the development of the nervous
system.
Epilepsy, ASD, and ID are considered to be disorders of the cerebral cortex, and of
cerebral connectivity. The proper formation of the cerebral cortex is dependent on several
processes, consisting of proliferation, differentiation, migration, axon and dendrite formation,
synaptogenesis, and pruning and stabilization of neuronal circuits. The role of mitochondria has
been explored in many of these processes, but our understanding of the importance of
mitochondria during neuronal migration is sparse. Deficits in neuronal migration, especially
interneurons, are postulated to play a role in many NDDs. Thus, I have focused my thesis work
on investigating the role of mitochondria during the process of neuronal migration in cerebral
cortical development, and how this role informs our understanding of the consequences of
mitochondrial dysfunction in disease.
1

Development of the Cerebral Cortex
The mammalian neocortex processes environmental stimuli and information into higher
cognitive behaviors such as planning and learning. It is a complex structure with six horizontally
organized layers made up of networks of neurons. The cortex consists of two basic cell types:
excitatory glutamatergic pyramidal projection neurons, and inhibitory GABAergic interneurons.
The circuits established by these two cell types maintain a delicate balance between excitatory
input, synchronization, and inhibitory tone that are essential for normal cortical function (Freund
and Katona 2007, Le Roux, Amar et al. 2008, Xue, Atallah et al. 2014). The formation of these
circuits depends on a series of complex neurodevelopmental processes, involving neurogenesis,
differentiation, neuronal migration, axon targeting, synaptogenesis, and coordinated apoptosis.
During the early stages of development, the forebrain emerges from cranial bulges of the
embryonic neural tube. The telencephalic region is specified during the rapid proliferation of
neuroepithelial cells (NECs) lining the neural tube with the expression of Foxg1 (Tao and Lai
1992, Shimamura and Rubenstein 1997). This region will generate the future neocortex,
hippocampus, basal ganglia, and olfactory bulbs. At this point, the developing nervous system
consists of two layers. The inner layer consists of a highly proliferative pseudostratified
ventricular zone (VZ), and the external or superficial layer is a relatively cell-sparse, process-rich
region known as the marginal zone (MZ)(Super, Soriano et al. 1998). There are also distinct
developmental regions of the early nervous system; a dorsal pallium which develops into the
cortex and hippocampus, and the ventral subpallium, where the future basal ganglia will reside.
NECs divide, generating a first wave of pioneer projection neurons out to form the basal
preplate (Rickmann and Wolff 1981). Subsequently, during the splitting of the preplate, the
earliest born layer 6 neurons migrate outward to establish the early subplate, or future cortical
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plate (CP) (Del Rio, Martinez et al. 2000). During this process, NECs lose epithelial
characteristics and transition into radial glial cells (RGCs), the precursor of excitatory projection
neurons (PNs) (for review, see (Gotz and Huttner 2005, Franco and Muller 2013)). These RGCs
reside in the VZ adjacent to the ventricles and send long projections towards the basal pial
surface. In addition to self-renewing and producing PNs, RGCs produce short neural precursors
(SNPs) and intermediate progenitor cells (IPCs). SNPs also reside in the VZ (Gal, Morozov et al.
2006), while IPCs migrate outwards and create a distinct region of proliferation referred to as the
sub-ventricular zone (SVZ)(Haubensak, Attardo et al. 2004, Miyata, Kawaguchi et al. 2004,
Noctor, Martinez-Cerdeno et al. 2004). During this process, a cell-sparse zone, known as the
intermediate zone (IZ) can be recognized separating the CP from the VZ/SVZ, populated by
afferent and efferent axons from pioneer neurons (Denaxa, Chan et al. 2001). As development
progresses, the dorsal pallium and ventral subpallium become markedly distinct from one another
morphologically. The subpallium develops dense protuberances that are identifiable at E11.5
known as the lateral, medial, and caudal ganglionic eminences. These distinct pallial and
subpallial regions serve as the sources of different neuronal cell type populations. Pyramidal
neurons are born in the proliferative zones in the VZ lining the dorsal pallium (Malatesta,
Hartfuss et al. 2000, Dehay and Kennedy 2007). In contrast, inhibitory interneurons (INs) of the
forebrain are born in the ventral pallium, in the medial, lateral, and caudal ganglionic eminences
in addition to the preoptic area (MGE, LGE, CGE) (Anderson, Eisenstat et al. 1997, Butt,
Fuccillo et al. 2005). These morphological regions have been further characterized by the
expression of transcription factors that contribute to fate determination of the variety of IN
subtypes found in the forebrain (Sussel, Marin et al. 1999, Stoykova, Treichel et al. 2000, Flames,
Pla et al. 2007).
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The birth of neuronal populations in specific regions of the developing brain presents a
unique challenge to the developing embryo to create heterogeneous circuits throughout the
cortex. Each of these populations must migrate from their origins from these proliferative zones
to properly incorporate into their final positions in the brain. There are three primary types of
neuronal migration that have been described in the mammalian forebrain; the radial migration of
cortical pyramidal cells (Nadarajah and Parnavelas 2002, Noctor, Martinez-Cerdeno et al. 2004),
the non-radial or tangential migration of cortical interneurons (Anderson, Eisenstat et al. 1997,
Wonders and Anderson 2005, Yokota, Gashghaei et al. 2007), and the chain migration of
interneurons migrating to populate the olfactory bulbs (Lois, Garcia-Verdugo et al. 1996, Pencea
and Luskin 2003). The migration of pyramidal neurons (PNs) and cortical interneurons (INs)
occur primarily during neurodevelopment. Chain migration, also referred to as the rostral
migratory stream (RMS), has been observed as early as E15 and continues in the adult brain
(Lois, Garcia-Verdugo et al. 1996, Pencea and Luskin 2003). Although these modes of migration
each have unique characteristics, the distinct regulation of each mode from one another has not
been well studied.
PNs are produced from dividing RGCs in the VZ, or from intermediate progenitor cells
(IPCs) located in the SVZ of the dorsal pallium (Tabata and Nakajima 2003, Noctor, MartinezCerdeno et al. 2004). The RG cells extend processes towards the pial surface and subsequently,
the nucleus moves cyclically within the cell soma between the borders of the VZ, dividing at the
ventricular border to produce IPCs or postmitotic PNs (Taverna and Huttner 2010, Wu, Gu et al.
2014). When the neocortex is thin, PN cells can exhibit a migratory behavior known as somal
translocation (Nadarajah, Brunstrom et al. 2001, Nadarajah and Parnavelas 2002), in which the
the cell soma of the neuron moves rapidly towards the pial surface through shortening of the pial
process. As the cortex thickens, post-mitotic PNs (likely both from RG and IPG divisions)
4

undergo a brief multipolar stage within the intermediate zone, and exhibit lateral movement
within the VZ and SVZ and IZ (Tabata and Nakajima 2003, Jossin and Cooper 2011). As the PNs
prepare to invade the cortical plate, they shift to a bipolar morphology, migrating radially
utilizing the RG processes as supportive scaffolding to reach their final destinations and at times
utilizing somal translocation at the end of their journey (Nadarajah and Parnavelas 2002). After
pre-plate splitting creates layer 6, the formation of the gross laminated structure of the cortex
forms in an inside-out fashion; subsequent waves of cells migrate past deeper layers to establish
the more superficial cortical layers (Figure 1) (Berry and Rogers 1965, Frantz and McConnell
1996, Kandel ER 2000).
Inhibitory interneurons of the cortex are born in the germinal zones of the MGE and CGE
and migrate long distances in a process called tangential migration (Anderson, Eisenstat et al.
1997, Wichterle, Turnbull et al. 2001). Like in the dorsal pallium, interneurons born are born in
the proliferative VZ/SVZ starting as early as 9.5 (Sussel, Marin et al. 1999, Butt, Sousa et al.
2008). Although the dynamics and behaviors of intermediate progenitors in the ventral pallium
are not as well studied as those in the cortex, it is thought that there are similarities in which
RGCs within the VZ produce IPCs in the SVZ, and these progenitor pools give rise to postmitotic
interneurons (Ross 2011). After their birth, newborn interneurons exit these proliferative zones
responding to local chemorepulsive cues and motogenic factors (Faux, Rakic et al. 2012, Marin
2013). Cortical interneurons must then navigate dorsally through the ventral pallium to reach the
cortex (Figure 1). This process is dependent on the creation of permissive corridors with a
combination of repellent cues to prevent migration into the striatum, attractive cues directing cells
towards the cortex, and motogenic factors that stimulate migration (for review, (Guo and Anton
2014)). At E12.5, these migrating interneurons begin to invade the cortex in streams from the
cortical notch (Marin and Rubenstein 2003). INs migrate across the processes of the radial glia,
5

moving freely through the cellular milieu of the cortex in a dorsomedial fashion, migrating
towards the dorsal curve of the cortex, and into the future hippocampus of the mouse. During this
time, INs exhibit highly dynamic migratory behavior; they are able to migrate between streams
and reverse direction. Whole brain explant cultures have indicated interneurons utilize this
random walk behavior, dispersing them throughout the cortex dorso-caudally. (Figure 1) (Ang,
Haydar et al. 2003, Metin, Baudoin et al. 2006, Tanaka, Maekawa et al. 2006, Tanaka, Yanagida
et al. 2009). INs also exhibit a radially-directed migration phase, in which they leave their
tangentially migrating streams, turn towards the ventricular surface, contact the ventricles, and
migrate radially outwards into the cortical plate (Figure 1) (Nadarajah, Alifragis et al. 2003). It is
theorized that INs utilize this radially directed migration as a final step reach their positions in the
cortical plate (Nadarajah, Alifragis et al. 2002). Although it has been thought that INs migrate
independently of RGCs, live imaging studies simultaneously imaging migrating INs and RGCs
suggest that interactions with RGCs regulate this radially directed stage of IN migration (Yokota,
Gashghaei et al. 2007).
During migration, INs exhibit dynamic changes in cell morphology. Migrating INs
extend a leading process in the direction of migration that extends, retracts, and branches (Lysko,
Putt et al. 2011, Lysko, Putt et al. 2014). The centrosome, coupled with the Golgi apparatus
moves forward into a thickening within the leading process (Bellion, Baudoin et al. 2005).
Nucleokinesis follows through a combination of molecular motors pulling on a microtubule cage
surrounding the nucleus, and actinomyosin contractions from the rear of the cell (Bellion,
Baudoin et al. 2005, Martini and Valdeolmillos 2010).
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Figure 1. Development of the cortex
(A) Projection neurons (PNs) are born in the ventricular zone (VZ) of the dorsal pallium (green
line), and migrate radially to their cortical positions in an inside-out fashion (green arrows).
Cortical interneurons (INs) are born in the VZ of the ventral pallium in the medial ganglionic
eminence (MGE; red line). They then migrate non-radially towards the cortex, invading the
cortex in two streams (red arrows). (B) The embryonic cortex is divided into the proliferative VZ
and subventricular zone (SVZ). Radial glia cells (RGCs, yellow) undergo cell somal
translocations between the ventricular surface and SVZ border (1a), and give rise to PNs (green)
(1b) and intermediate progenitor cells (IPCs, light green) that reside in the SVZ. (1c). Both PNs
and IPCs can become multipolar cells (2a) that move throughout the SVZ and intermediate zone
(IZ), (2b) before transitioning to bipolar radially migrating PNs that invade the cortical plate
(CP), utilizing RGCs as scaffolding to guide their migration. Migrating INs invade the cortex in
two streams in the IZ, and MZ. These cells migrate tangentially to the RCG scaffolding (3a), and
can move across the CP between streams (3b). Additionally, these INs will move toward the
ventricles, and undergo a radially directed migration to reach their final destinations in the cortex
(3c). (C) Interneurons undergo morphological changes throughout their migration. Centrosomes
are located in close association with the nucleus in the cell soma (1). The centrosomes move
7

forward into the leading process, creating a thickening (2). During nucleokinesis, the forward
movement of the nucleus and cell soma toward the centrosome results in the formation of a
trailing process (3). The trailing process retracts, completing the migration cycle (4).
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Disorders of neuronal migration
Genetic mutations that interfere with the radial migration of PNs often result in gross
abnormal cortical structure. The most severe of these disorders, Lissencephaly, causes an
absence of the folds, or gyri of the brain, resulting in a smooth brain. The majority of cases of this
disorder are caused by defects in Lis1 and DCX, genes that regulate microtubule dynamics (Pilz,
Matsumoto et al. 1998).
Defects in interneurons’ migration can result in the reduction or absence of interneurons
within the cortex. Because interneurons compromise approximately 20% percent of the neurons
in the cortex, loss or reduction of these cells does not impact gross cortical structure. However,
the loss of these cells has significant impacts on cortical function. Reduction, absence, improper
synapse formation, or abnormal behaviors of interneurons are linked to various neurological
disorders, termed interneuronopathies (Kato and Dobyns 2005, Rivero, Selten et al. 2015, Marsh,
Nasrallah et al. 2016).
Mitochondrial functions within the cell
Mitochondria are complex self-replicating, double membrane organelles found within the
eukaryotic cells. Mitochondria are known as the “powerhouse” of the cell (Philip Siekevitz 1957),
generating significant amounts of ATP. In addition to their role in energy production,
mitochondria play key roles in the regulation of redox homeostasis, steroid synthesis, calcium
buffering, and apoptosis (McBride, Neuspiel et al. 2006).
The inner and outer mitochondrial membranes create distinct regions into which
mitochondrial functions can be separated. A prime example is the generation of ATP by
mitochondrial oxidative phosphorylation (OXPHOS). Glucose is imported through the cell
membrane via glucose transporters. Cells generate 2 ATP via glycolysis in the cytosol, converting
9

glucose to two molecules of pyruvate (Figure 2). Subsequently, pyruvate diffuses through the
outer mitochondrial membrane where the mitochondrial pyruvate carriers (MPC1/2) transport it
into the inner mitochondrial matrix (Bricker, Taylor et al. 2012, Herzig, Raemy et al. 2012).
Within the inner mitochondrial matrix, pyruvate is converted into Acetyl-CoA, and these two
molecules enter the TCA cycle, producing reducing equivalents of NADH, and FADH2. The
electron transport chain, consisting of various protein complexes in the inner mitochondrial
membrane, harnesses the oxidation of NADH and FADH2 to pump hydrogen ions into the
intermembrane space (for review, see (Saraste 1999)). This creates an electrochemical gradient
with which ATP synthase utilizes to generate ATP. This ATP must be transported out of the
matrix via the adenine nucleotide transporter (Ant) into the intermembrane space, to allow ATP
generated from OXPHOS to be released into the cytosol for use by the cell (Levy, Chen et al.
2000, Klingenberg 2008). ATP diffusion through the cytosol is thought to be insufficient to meet
high local energetic demands of the cell (Clegg 1984). This is overcome by energy shuttling
pathways, such as creatine kinase/creatine phosphate and adenylate kinase (Ames 2000),
clustering of glycolytic enzymes(Beeckmans, Van Driessche et al. 1990), and localization of
mitochondria to areas of need (Zinsmaier, Babic et al. 2009).
Although mitochondria are central to various cellular functions the differences in
mitochondrial biology, such as genetic regulation, proteomic expression, and localization
behavior between different cell types and developmental time points, has not been well studied.
Proteomic differences of mitochondrial enzymes have been detected between tissue types,
(Johnson, Harris et al. 2007) establishing evidence for the heterogeneity of mitochondria within
vertebrates. Recent studies examining the mitochondrial proteome during brain development have
revealed drastic changes in mitochondrial protein expression, suggesting changes in
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mitochondrial function and behavior may be a strategy throughout development for differentially
regulating aspects of cell physiology and behavior (Nakai, Taniuchi et al. 2000).
Mitochondria in Neurons
Neurons are considered to be one of the body’s most energetically demanding cell types:
the CNS consumes 20% of the body’s resting metabolism (Silver and Erecinska 1998). As
previously discussed, cells can generate energy via glycolysis or oxidative phosphorylation. In
vitro comparison of cytosolic vs. mitochondrial ATP production has suggested that embryonic
neurons have mostly glycolytic metabolism, and postnatal neurons utilize oxidative
phosphorylation (Surin, Khiroug et al. 2012). The main failing of these studies is the
generalization of neuronal cell types; only hippocampal pyramidal cultures were assessed.
Considering the substantial differences between PNs and INs, it is possible that their metabolic
profiles are distinct.
Previous histological studies noted mitochondrial were localization in particular areas of
neurons, including dendritic shafts and spines (Cameron, Kaliszewski et al. 1991, Popov,
Medvedev et al. 2005), Nodes of Ranvier (Berthold, Fabricius et al. 1993, Fabricius, Berthold et
al. 1993), axon growth cones (Hollenbeck and Saxton 2005), and synapses (Palay 1956),
suggesting that mitochondria are targeted to particular regions of high energetic demand and are
likely important for neurologic function.
Neuronal mitochondria are incredibly dynamic structures, with both static and motile populations
(Hollenbeck and Saxton 2005, Zinsmaier, Babic et al. 2009) undergoing fusion and fission
(Alexander, Votruba et al. 2000, Lee, Sterky et al. 2012, Berthet, Margolis et al. 2014). Kinesin
and dynein allow for the anterograde and retrograde movement along the microtubules while
various proteins anchored to the mitochondrial membrane regulate their attachment to these
11

molecular proteins (Hirokawa and Takemura 2005, Pilling, Horiuchi et al. 2006). Some of these
adaptor proteins, such as syntabulin, have dual functions in mediating vesicular transport in
addition to trafficking mitochondria (Cai, Gerwin et al. 2005). The adaptor protein Milton
facilitates the interaction between the mitochondrially bound protein, mitochondrial RhoGTPase
(Miro) and kinesin (Liu and Hajnoczky 2009, Chen and Sheng 2013). In response to elevated
Ca2+, it is hypothesized that Miro releases kinesin, and binds syntaphilin (SNPH), a protein
responsible for anchoring axonal mitochondria (Kang, Tian et al. 2008). This system allows for
regulation of mitochondrial localization during synaptic activity (Yi, Weaver et al. 2004).
Fusion and fission of mitochondria are regulation points for mitochondrial morphology,
adapting to cellular energetic needs, as well as maintaining mitochondrial health (reviewed in
(Bertholet, Delerue et al. 2016)). Mitochondrial fusion is regulated by Mitofusin (Mfn) 1 and 2,
which fuse the outer mitochondrial membrane, and Optic atrophy 1 (Opa1), which fuses the inner
mitochondrial membrane. Dynamin-related protein 1 (Drp1) and Ganglioside Induced
Differentiation Associated Protein 1 (GDAP1) are central regulators of mitochondrial fission
(Smirnova, Shurland et al. 1998, Niemann, Huber et al. 2014). Posttranslational modification of
Drp1 by phosphorylation (Cribbs and Strack 2007), ubiquitination (Karbowski, Neutzner et al.
2007), and sumoylation (Harder, Zunino et al. 2004) regulates its activity and ability to bind to
mitochondria. These proteins have been implicated in neurodegenerative diseases (DuBoff, Gotz
et al. 2012, Bertholet, Millet et al. 2013, Niemann, Huber et al. 2014), and their role in neuronal
development has only recently been explored (Fang, Yan et al. 2016).
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Figure 2. Mitochondrial Oxidative Phosphorylation
(A) Glucose is taken up by the cell, where it can be ultilized via glycolysis in a non-reversible
process to generate 2ATP and pyruvate. Glycolysis can be inhibited by 2-deoxy-glucose (2DeOG). Pyruvate is transported into the inner mitochondrial matrix (IMM) via mitochondrial
pyruvate carriers (Mpc) 1 and 2. Once within the IMM, pyruvate is converted to Acetyl-CoA,
and utilized in the TCA cycle to produce reducing equivalents of NADH and FADH2. The
electron transport chain in the inner mitochondrial membrane utilizes NADH and FADH2 from
the TCA cycle to pump hydrogen ions out of the IMM, resulting in an electrochemical gradient.
ATP synthase utilizes this gradient to synthesize ATP. ATP must be transported out of the IMM
via adenine nucleotide transporters (Ant) 1 and 2, and diffuse through the outer mitochondrial
membrane to the cytosol for utilization by the cell. Ant1/2 are inhibited by Bongkrekic Acid
(BA).
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Mitochondrial disorders in disease
Mitochondrial diseases (MDs) are considered the most common of the inherited
metabolic disorders (Schaefer, Taylor et al. 2004). Diagnosis of mitochondrial disorders can be a
clinical challenge, as there is much variability in symptomatology; MDs can be single or
multisystemic, and can vary in severity and age of onset. One reason for the complicated nature
of mitochondrial diseases is that they contain their own mitochondrial DNA (mtDNA). In contrast
to the two copies of nuclear DNA, cells contain many more copies of mtDNA, which undergo
constant replication. This makes mtDNA more susceptible to generating mutations (Chinnery and
Samuels 1999). It is common for individuals with pathogenic mtDNA mutations to have
heteroplasmy; a mixture of wild-type and mutated mtDNA. The proportion of wild-type versus
mutated mtDNA can vary between patients, organ systems, and even cell types, and have effects
on pathogenesis (Chinnery and Schon 2003).
MDs to tend to cause clinical manifestations in highly energetic organs, such as brain and
muscle. Traditionally, mitochondrial diseases have been studied in the context of the adult
nervous system. Mutations in mitochondrial proteins are found in many neurodegenerative
disorders, such as Charcot-Marie-Tooth (CMT) subtype 2A, amyotrophic lateral sclerosis (ALS),
Parkinson's, Huntington's, Dominant Optic Atrophy, and Alzheimer's disease (Calkins, Manczak
et al. 2011, Manczak and Reddy 2012, Chaturvedi and Flint Beal 2013). Although mutated genes
in these disorders have varied impacts on ROS regulation, mitophagy (the process by which cells
remove damaged mitochondria), OXPHOS and calcium homeostasis, it is suggested that these
pathways converge in deficient cellular respiration leading to neuronal loss.
In recent years, interest in mitochondrial dysfunction has expanded from
neurodegeneration to include diseases of neuronal dysfunction. Patients with mutations in
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mtDNA or other mitochondrial proteins often present with epilepsy; a subset of which are
characterized as neonatal or early onset (Khurana, Valencia et al. 2013). Although the mechanism
by which mitochondrial mutations cause epilepsy are unknown, it has been hypothesized that
increased oxidative stress and energetic compromise disrupt Ca2+ hemostasis, modulating
synaptic activity and transmission (Chang and Yu 2010). Conversely, epilepsy has also been
found to precede mitochondrial dysfunction in clinical and animal models of epilepsy (Kudin,
Kudina et al. 2002, Chuang, Chang et al. 2004, Khurana, Valencia et al. 2013). It is thought that
seizure activity can down-regulate the expression of OXPHOS related proteins, particularly
complex I, and the subsequent energetic deficiencies increase neuronal death, contributing to
further pathogenesis (Kunz, Kudin et al. 2000, Sleven, Gibbs et al. 2006, Chen, Chang et al.
2010, Folbergrova, Jesina et al. 2010).
The first evidence of that mitochondrial mutations could result in autism was published in
1999 (Sue, Bruno et al. 1999). Since then, multiple ASD patients have been found to harbor
mtDNA mutations and mutations in somatically encoded mitochondrial DNA (reviewed in
(Legido, Jethva et al. 2013)). Metabolic abnormalities indicative of mitochondrial dysfunction
have also been described in patients, including elevation of lactate, pyruvate, and alanine in
blood, cerebrospinal fluid, or brain tissues, and electron transport chain abnormalities in
peripheral tissues (Legido, Jethva et al. 2013). There is not yet clear evidence if mitochondrial
dysfunction contributes to the pathogenesis of ASD, or if it is an epiphenomenon (Rossignol and
Frye 2012). Most hypotheses involving mitochondrial dysfunction and autism suggest that
deficits in energy can result in post-natal malfunctioning of neuronal circuits, or that
mitochondrial dysfunction can result in immune-mediated deficits resulting in damage to the
developing or postnatal brain (Legido, Jethva et al. 2013).
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Mitochondria in cell migration
Migration likely places unique metabolic demands on a cell. In non-neural migratory
cells, mitochondrial function and localization are essential for normal migration. Upon activation
and subsequent chemotaxis, leukocyte mitochondria are observed to mobilize to the posterior
uropod (Campello, Lacalle et al. 2006). This process requires a balance between mitochondrial
fusion and fission. The inability of mitochondria to target to this region abrogates chemotaxis.
Additionally, ATP provided by mitochondrial oxidative phosphorylation is required to
phosphorylate myosin II (Campello, Lacalle et al. 2006). Interestingly, during the migration of
endothelial cells (EC), PFKFB, a glycolytic activator, localizes to the actin network for
lamellipodia. This production of glycolytic ATP is required for EC migration, while oxidative
phosphorylation is not required (De Bock, Georgiadou et al. 2013), suggesting that the energetics
of cell migration vary depending on cell type.
Abnormal mitochondria have been described in genetic mutants with defects in radial
migration. Lis1 and DCX cause lissencephaly, and are known to cause radial and non-radial
migration defects. These two factors associate with the perinuclear microtubule cage region, and
facilitate nucleus-centrosome coupling during migration (Tanaka, Serneo et al. 2004). Lis1
regulates cytoplasmic dynein function, resulting in clustering of dynein around the centrosomes
in MEF cells (Yamada, Toba et al. 2008, Yamada, Yoshida et al. 2009). Subsequently,
mitochondria and β-COP-positive vesicles have a perinuclear localization rather than being
widely distributed. However, it is unclear what the contribution to defects in migration
mitochondria may have in this model, or if the mislocalization characterized in the MEF cells is
present in PN or INs during migration. In DCX mutants, mitochondria have abnormal
morphology in P0 hippocampal pyramidal cells (Khalaf-Nazzal, Bruel-Jungerman et al. 2013),
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but further examination of mitochondrial pathologies during earlier developmental stages, and
assessment of mitochondrial function and localization is lacking.
In one model of abnormal radial migration, mitochondrial localization was assessed.
Tau1 is a microtubule-associated protein implicated in Alzheimer’s, neurodegenerative disorders
and ID. (Weingarten, Lockwood et al. 1975, Shaw-Smith, Pittman et al. 2006, Sapir, Frotscher et
al. 2012). Reduction of Tau in PNs reduces radial migration, and causes thinning and
malformation of migrating PN leading processes (Sapir, Frotscher et al. 2012). In these migrating
PNs, mitochondrial mobility into the leading edge of PNs is abrogated, and their processes
became vacuolated and abnormal in shape. Although each of these disease models suggests that
mitochondria may have a role in radial migration, each of these proteins has additional functions
in microtubule dynamics. Thus, it is unclear if these effects on neuronal migration are due to
effects on microtubule dynamics, or mitochondrial behavior.
Mitochondria-localized glutamic acid-rich protein (MGARP), was recently characterized
as a negative regulator of radial migration (Jia, Liang et al. 2014). Unlike Lis1 and DCX, this
protein is localized specifically to mitochondria and is typically lowly expressed in neurons, is
significantly upregulated during hypoxia (Li, Lim et al. 2009). Overexpression, or knockdown of
this protein in radially migrating neurons using in utero electroporation impedes normal
migration and interferes with the development of neuronal processes (Jia, Liang et al. 2014). At
P0, and in cultured cells, mitochondria displayed rounded morphologies, reduced localization in
processes and reduction in mitochondrial numbers. In cultured embryonic neurons, mitochondria
also displayed reduced motility within axons. Although this is a more promising indication that
regulation of mitochondria is important for neuronal migration, it is unclear how these changes in
MGARP levels impact mitochondrial localization during the migration, and if changes in
MGARP can impact IN migration. Currently, the function of MGARP is still unclear. It has been
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suggested that MGARP is involved in steroidogenesis (Matsumoto, Minegishi et al. 2009), and
can impact mitochondrial abundance in addition to its morphology, but it is unknown if additional
aspects of mitochondrial function are compromised by MGARP manipulations.
In interneurons, mitochondria have been described in particular locations in migrating
interneurons, but not studied in depth. Schaar et. al. utilized presence of mitochondria to assist in
identification of the trailing process in electron microscopy preparations of migrating INs in vitro
(Schaar and McConnell 2005). Additionally, mitochondria have been observed paired with
centrosomes and Golgi apparatus within the thickening of the leading process during the forward
movement of centrosomes (Bellion, Baudoin et al. 2005). These observations suggest
mitochondria may cluster within certain regions of interneurons during the migration cycle, but
analysis of mitochondrial localization within migration INs has not been done.
To address this knowledge gap, we, therefore, utilized time-lapse imaging of live cells to
observe mitochondrial behavior in actively migrating PNs and INs. We found distinct
mitochondrial localization patterns in PNs compared to INs. In PNs, the majority of mitochondria
maintain their localization in anterior of the nucleus. In contrast, mitochondria in migrating INs
cycle throughout the cell, moving from anterior to the nucleus, forward into the cytoplasmic bleb,
and moving back the trailing process during nucleokinesis.
To investigate if there are differential requirements for mitochondrial function in these
two migrating populations, we assayed the effect of pharmacological inhibition of mitochondrial
oxidative phosphorylation in migrating interneurons. Glycolysis alone is insufficient for IN
migration, and INs in which OXPHOS is inhibited, INs exhibit increases in directional changes
and slowing of migration. In slice culture, pharmacological inhibition of oxidative
phosphorylation reduces IN migration without impacting that of PNs.
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We saw the same impact in Ant1 mutants, where the translocation of ATP generated
from OXPHOS into the cytosol is compromised. Mutants displayed reduced INs invading the
cortex, and alterations in migratory behavior including reduced migration speed and decreased
progressive migration, while radial migration was unaffected. Interestingly, Ant1 mutant INs
centrosomes were mislocalized, suggesting that centrosome location and IN polarity are sensitive
to metabolic perturbations.
We then attempted to alter mitochondrial trafficking behavior by expressing a dominant
negative form of Miro1, a protein involved in mitochondrial trafficking during IN and PN
migration. Although we did not see changes in IN migration rate, we observed a consistent
phenotype of increased direction changes which subsequently reduced the ability of interneurons
to invade the cortex. These consistent changes in cell migration behavior suggest that
mitochondria are required for the regulation of IN polarity to allow for progressive interneuron
migration.
These data collectively support a model of differential requirements for mitochondria
between interneurons and pyramidal neurons during migration, and suggests a potential pathway
for selective disruption of interneurons during early fetal development.
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CHAPTER 2 - DIFFERENTIAL MITOCHONDRIAL REQUIREMENTS FOR RADIALLY
AND NON-RADIALLY MIGRATING CORTICAL NEURONS: IMPLICATIONS FOR
MITOCHONDRIAL DISORDERS

Introduction
Mitochondrial diseases (MDs) are the most common inherited metabolic disorder, with
an estimated prevalence of 1:5000 (Schaefer, Taylor et al. 2004). Although MDs consist of a
spectrum of disorders that can involve single or multisystem presentations, neurological
symptoms are common clinical characteristics. In recent years, clinical, genetic, and biochemical
studies have revealed an emerging link between mitochondrial dysfunction and
neurodevelopmental disorders, including intellectual disability (ID) (Kaplan, Cao et al. 2012,
Valenti, de Bari et al. 2014) childhood epilepsy (El Sabbagh, Lebre et al. 2010, Chevallier, Von
Allmen et al. 2014) and autism spectrum disorder (ASD) (Giulivi, Zhang et al. 2010, Rossignol
and Frye 2012). Interestingly, these conditions have also been associated with interneuron
dysfunction (Marin 2012, Olivetti and Noebels 2012). The correlation between MDs and
childhood neurological disorders raises the question as to whether interneuron development is
particularly dependent on mitochondrial function.
Recent studies have elucidated roles for mitochondria in multiple aspects of
neurodevelopment including neuronal differentiation (Wang, Ye et al. 2014), process outgrowth
(Cheng, Wan et al. 2012, Kimura and Murakami 2014), and synaptogenesis (Bertholet, Millet et
al. 2013). Most of these studies have utilized glutamatergic hippocampal neurons as a model,
leaving the contribution of mitochondria to interneuron development relatively unexplored. Since
interneurons are thought to be a key factor in the pathogenesis of epilepsy and ASD, we were
particularly interested in examining mitochondrial behavior and function during developmental
processes for which there are distinct features between glutamatergic projection neurons (PN) and
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GABAergic interneurons (IN) in the cortex. During developing PN and IN are derived from
distinct locations and take different migration routes: PNs migrate along radial glial fibers from
their origin in the dorsal ventricular zone (VZ) and maintain a relatively stable morphology
oriented towards the pial surface (Noctor, Martinez-Cerdeno et al. 2004). In contrast, cortical INs
take a circuitous path from their origin in the subcortical ganglionic eminences. Along the way,
migrating INs frequently pause, change direction, and exhibit extensive branching dynamics of
the leading process (Polleux, Whitford et al. 2002, Bellion, Baudoin et al. 2005, Lysko, Putt et al.
2011, Lysko, Putt et al. 2014).
Given the greater distance and dynamic nature of IN migration, we reasoned that it
requires more energy than does the migration of PNs. First, we found that the mitochondria
within INs have a highly dynamic localization pattern during non-radial migration. In contrast,
mitochondria remain more consistently localized in radially migrating PNs. Second, we found
migrating interneurons to be exquisitely sensitive to agents that block the utilization of ATP
generated through oxidative phosphorylation. Remarkably, glycolysis alone is insufficient for
normal IN migration but is able to support the radial migration of PNs. Moreover, the genetic
disruption of mitochondrial oxidative phosphorylation (OXPHOS) in mice lacking Ant1 was
associated with dramatic alterations of IN migratory morphology and behavior, including
mispositioning of the centrosomes. Conversely, Ant1-/- PNs appeared normal in our migration
assays. These data suggest that interneuron polarity during migration is particularly sensitive to
metabolic disruptions and that OXPHOS is required for normal migration of INs but not PNs.
Our results also imply that the symptomatic manifestations of mitochondrial dysfunction and
related conditions, including hypoxic injury, on cerebral cortical function may be secondary to
their selective impact on cortical interneuron migration.
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Results
Mitochondria are highly dynamic during interneuron migration
To examine the role of mitochondria in non-radial versus radial migration, we first sought
to characterize the localization of mitochondria in migrating INs and PNs. We classified medial
ganglionic eminence (MGE)-derived cells migrating in explant cultures into three morphological
classes corresponding to distinct phases of their migration: leading process extension, forward
movement of the centrosome, and nucleokinesis/trailing process retraction (Marin, Valdeolmillos
et al. 2006). Morphology 1 cells were defined to have slender, tapered leading processes;
morphology 2 cells have a bleb or thickening of the leading process; while morphology 3 cells
have a clear trailing process (Figure 3A). Each subgroup displayed a distinct distribution of
mitochondria (Figure 3B). In morphology 1, mitochondria were concentrated immediately
anterior to the nucleus (Figure 3C, 49 ± 4%, % of total mitochondrial area (%TMA) ± SEM, 5fold greater % TMA/% total cell area(TCA), p < 0.05) (Golden, Zitz et al. 1997, Bellion,
Baudoin et al. 2005). In morphology 2 cells, mitochondria were concentrated in the cytoplasmic
bleb (Figure 3C, 71 ± 2, %TMA ± SEM, 3.9-fold greater %TMA/%TCA than other areas, p <
0.05), while in morphology 3, the mitochondria were aggregated in the trailing process and
posterior nuclear area (Figure 3C, 29 ± 4 %TMA ± SEM, 39% ± 5 TMA ± SEM respectively,
1.7-fold greater %TMA/%TCA than other areas p < 0.05) (Bellion, Baudoin et al. 2005).
Although these independent clustering behaviors have been noted in the literature,
mitochondrial dynamics during migration have not been studied. To evaluate the subcellular
localization of mitochondria in relation to the morphological migratory phases, we next
performed time-lapse imaging of fluorescently labeled mitochondria in migrating interneurons in
vitro. Interestingly, mitochondria displayed consistent positional reorganization during migration,

22

Figure 3. Mitochondrial localization in migrating neurons.
(A) Schemata of interneuron (IN; 1-3) morphologies displayed during migration. (B) Confocal
immunofluorescence (IF) images of mitochondria in migrating INs in vitro displaying varying
localization patterns. Cytosol (GFP), mitochondria (TOM20), nuclei (DAPI). Scale bar = 10 µm.
(C) Quantification of mitochondrial clustering in subcellular locations. Region I: trailing process
(TP); II: overlapping nucleus (Nuc); III: 5 µm anterior to the nucleus (5 µm AN); IV: cytoplasmic
bleb (bleb); V: leading process (LP); VI: leading process tip (LPT). Clustering varied markedly
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between IN morphologies. IN morphology 1 clustered in III, *p = 0.039. IN morphology 2,
clustered in IV, *p = 0.02, while IN morphology 3 clustered in I, and II, *p = 0.0343, ***p =
0.0002. Bars represent median with 25-75th percentiles ± min/max value of percent total
mitochondrial area (%TMA) normalized to region’s percent of total cell area (%TCA). n = 15
cells each type; Freidman’s test with Dunn’s correction. (D) Schemata of pyramidal neuron (PN)
migration morphology. (E) Confocal IF images of mitochondria in representative migrating PN.
Cytosol (GFP), mitochondria (MitoDsRed), nuclei (DAPI). Scale bar = 10 µm. (F) Quantification
of clustering mitochondria in migrating PNs. Region I: TP; II: Nuc; III: 5 µm AN; IV:
cytoplasmic bleb (bleb); V: LP; VI: leading process tip LPT. III vs. I and II: *p = 0.0327; III vs.
VI: ****p < 0.0001; V vs. VI: **p = 0.0064. n = 15 cells; Freidman’s test with Dunn’s
correction. (G) Time-lapse imaging of a migrating Dlx5/6CIG IN in vitro (cytosol, GFP;
mitochondria, Mitotracker® Red CMXRos) shows intracellular movement of mitochondria. 1
frame = 10 minutes. Scale bar = 10 µm. (H) Quantification of INs displaying extensive
movement of mitochondrial through the cell compared to cells where cyclical movement was not
observed. The majority of INs showed this movement of mitochondria throughout the cell during
migration. p < 0.0001, unpaired t-test, n = 5 independent cultures, 200 cells. Values represent
mean ± SEM (I) Live time-lapse imaging of a migrating PN (cytosol, GFP; mitochondria,
MitoDsRed). 1 frame = 10 minutes. Scale bar = 10 µm. (J) Quantification of PNs mitochondrial
movement through the cell versus those where the mitochondria remain confined. PNs exhibited
fixed localization in front of the nucleus. p = 0.002, Mann-Whitney, n = 6 independent cultures,
82 cells. Values represent mean ± SEM.
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as their subcellular location changed in concert with the morphology of the migrating cell (Figure
3G and 3H). The mitochondrial localization and changes in location observed in the three IN
morphologies were confirmed by characterization of mitochondria in the cortex of E13.5
Dlx5/6CIG embryos (Figure 4A, B). The localization of mitochondria in migrating INs was ranked
according to morphology as matching or not matching the localization observed in migrating
dissociated INS and found to be highly correlated (Figure 4B, C).
In contrast to migrating INs, migrating PNs maintain a relatively consistent migratory
morphology after leaving their multipolar phase in the ventricular and subventricular zones
(Figure 3D and 3I) (Noctor, Martinez-Cerdeno et al. 2004). During radial migration in the cortical
plate, mitochondria were found primarily anterior to the nucleus and in the leading process,
showing little change in regional localization (Figure 3E, 3F, 3I, and 3J). These data reveal that
the intracellular position, and changes in location, of mitochondrial of INs and PNs are clearly
distinguishable and suggest that there may be differences in energy requirements between these
two neuronal cell populations during development.
Oxidative phosphorylation is necessary for normal IN migration, but not for radial
migration
To determine whether migrating INs and PNs have distinct energetic requirements, we
studied their need for mitochondrially-generated ATP in explant and slice cultures. Cells generate
ATP through glycolysis in the cytosol and oxidative phosphorylation (OXPHOS) in the
mitochondria. To test whether OXPHOS is necessary for normal neuronal migration, we
examined cell movement after blocking OXPHOS with either oligomycin or bongkrekic acid
(BA). Oligomycin (Olig) blocks mitochondrial production of ATP by inhibiting the ATP synthase
(Kulka and Cooper 1962), while BA prevents the translocation of ATP across the inner
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Figure 4. Mitochondrial localization in interneurons in vivo
(A) Representative confocal z-slices of IN morphologies I-III showing mitochondria in INs
within the cortex. Cytosol (GFP), mitochondria (Tom20), nuclei (DAPI). Scale bar = 5 µm. (B)
Cells were visually scored as matching or non-matching to localization patterns seen in vitro (n=
5 individuals, ≥ 50 cells each morphology. (C-E) Quantification of mitochondria in regions.
Region I: trailing process; II: overlapping nucleus; III: 5 µm anterior to nucleus; IV: cytoplasmic
bleb; V: leading process. Similar to in vitro data, clustering varied between morphologies.
Morphology 1 clustered in III, *p ≤ 0.029. Morphology 2, clustered in IV, *p ≤ 0.022. Clustering
within the trailing process of morphology 3 was not as distinct compared to in vitro data.
Clustering was higher in region I compared to region II (p < 0.0001), most mitochondria clustered
in region III (p = 0.04). Median with Tukey distribution; dots = greater than 1.5 times
interquartile range of the percent total mitochondrial area (%TMA) normalized to region’s
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percent of total cell area (%TCA). n ≥ 50 cells each morphology from 5 different individuals.
Freidman’s test with Dunn’s correction.
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mitochondrial membrane by inhibiting the adenine nucleotide translocator isoforms 1 (Ant1, also
known as Slc25a4) and 2 (Ant2 also known as Slc25a5)(Henderson and Lardy 1970). IN
migration was exquisitely sensitive to Olig treatment, where 0.02 µM reduced IN migration by
78% (Figure 5A). Treating INs with 2.5 µM BA reduced IN migration by 50% (p ≤ 0.001)
(Figure 6A). These cells showed no reduction in somal translocation (Figure 6C, not statistically
significant but trending towards slower) but a significant increase in the time spent paused
(Figure 6D). Interestingly, treated cells exhibited elongated trailing processes (Figure 6B, 6F), a
higher frequency of trailing processes (Figure 6E) and for more time (Figure 6G) than controls.
Furthermore, at low BA concentrations, migrating INs exhibit a 10-fold increase in direction
changes (Figure 6H). BA also resulted in significant reduction in the leading process length
(Figure 6I). The leading processes also branched less frequently, and the branch lengths were
significantly reduced (Figures 6J and 6K).
To determine whether OXPHOS is sufficient to supply energy for IN migration, we
removed glucose (GLUC) from the medium or inhibited glycolysis with 2-deoxyglucose (2-DG)
and provided the OXPHOS substrate pyruvate (PYR). Alternatively, we substituted GLUC for
galactose (GAL). GLUC deprivation reduced migration by ~53% (Figure 5C), while inhibition
with 2-DG reduced migration by ~68% (Figure 5C). When INs are supplemented with PYR or
GAL, ATP generation is dependent on OXPHOS alone (Marroquin, Hynes et al. 2007, AdevaAndany, Lopez-Ojen et al. 2014). Both PYR and GAL were sufficient to rescue IN migration
fully under conditions of glycolysis inhibition, and this ability to sustain migration was abrogated
with the addition of sub-threshold doses of BA (Figure 5C). Therefore, OXPHOS is both
necessary and sufficient for normal IN migration.
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Figure 5. Oligomycin treatment of INs impacts migration
(A) Oligomycin treatment reduced IN migration rates (µm/min ± SEM, Oligo: p <0.0001, N = 3
independent cultures, 150 cells each, Mann-Whitney) (B) Representative phase image of treated
cells. Yellow arrows = extended trailing processes. (C) OXPHOS substrate pyruvate (Pyr)
rescues decreased migration from glucose deprivation and 2-Deoxyglucose (2-DG) treatment. Pyr
= pyruvate, Gluc = glucose, 2-DG = 2-deoxyglucose, BA = bongkrekic acid. p ≤ 0.001 as
indicated, n = 5 independent experiments, >75 cells each, Kruskal-Wallis with Dunn’s correction.
Data not shown for Galactose.
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Figure 6. Pharmacological inhibition of OXPHOS reduces IN migration.
(A) Inhibiting OXPHOS with BA decreased IN migration (all in µm/min ± SEM; 0 vs. 2.5 or 5, p
≤ 0.001, n = 5 independent cultures, >150 cells each, ANOVA test). (B) Representative phase
image of BA treated MGE INs. Arrows identify elongated trailing processes. Scale bar = 50 µm.
(C) Somal translocation for migrating IN, while slightly slower, did not reach significance.
(µm/min ± SEM; p ≤ 0.075, n = 5 independent cultures, >150 cells each, unpaired t-test test,
Welch’s correction). (D) BA treated neurons spend more time paused compared to control cells
(total time paused/imaging period ± SEM; p ≤ 0.002, n = 5 independent cultures, >150 cells each,
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unpaired t-test test, Welch’s correction). (E) Inhibition of OXPHOS had impacts on the trailing
process (TP) frequency (p <0.001, unpaired t-test with Welch’s correction, mean ± SEM), (F) TP
length (p < 0.0001, Mann Whitney, median with interquartile range ± min/max), and (G) TP life
(p < 0.0001, Mann-Whitney). For each, n = 5 independent cultures, 100 cells each. (H) OXPHOS
inhibition also causes increases in direction changes (mean direction changes/hour ± SEM, p <
0.0001; n = 5 independent cultures, 100 cells each, unpaired t-test with Welch’s correction). (I-K)
BA treatment impacted leading process length, branches/cell, and branch length (p < 0.0001, p <
0.001, and p < 0.0001 respectively, Mann Whitney). (L) Sample migration paths of INs (yellow)
and PNs (red) in E16 brain slices treated with vehicle or 20 µM BA. CP = Cortical plate, IZ =
Intermediate Zone, VZ = Ventricular Zone. Scale bar = 150 µm. (M) IN migration rates
decreased in slices treated with BA (p = 0.0023, n = 6 individuals, 20 INs each) whereas PNs
were unaffected (p > 0.05, n = 6 individuals, ≥ 15 PNs in each). Unpaired t-test with Welch’s
correction, mean ± SEM.
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The requirement for OXPHOS in neuronal migration was further tested using slice
cultures where both non-radially migrating INs and radially migrating PNs could be studied
simultaneously. We utilized Dlx5/6CIG mice in which the INs are genetically labeled with eGFP.
At E14, a DsRed expression construct was electroporated into Dlx5/6CIG embryos to label the
progenitors of radially migrating PNs. Embryos were harvested at E16, and cortical slices from
individuals were treated with BA. Remarkably, BA treatment reduced IN migration rates whereas
PNs were unaffected (Figure 6L, 6M; IN: 0.289 ± 0.06 µm/min decrease, p < 0.002, PN: 0.03 ±
0.02 µm/min increase, p > 0.1). These data demonstrate that the non-radial migration of cortical
interneurons is dependent on OXPHOS, while the radial migration of cortical projection neurons
is either not or minimally OXPHOS dependent.
Selective disruption of non-radial IN migration in Ant 1 -/- mutants
We next sought to corroborate our pharmacologic data of the differential effects of
OXPHOS on PN versus IN migration in mice lacking the Ant1 isoform. The genetic removal of
Ant1 reduces the ATP flux from the mitochondria to the cytosol, and Ant1 is expressed in cortical
neurons, including INs (Figure 7A and 7B)(Graham, Waymire et al. 1997, Levy, Chen et al.
2000, Lee, Schriner et al. 2009).
To determine if loss of Ant1 disrupts IN migration in vivo, Ant1+/+ and Ant1-/- brains were
sectioned and stained for calbindin at E13.5 to detect a subset of migrating INs. On average, the
leading edge of INs from wild-type brains migrated 15% percent farther than that of Ant1-/- brains
(Figure 8A, 8B), and there was a 30% decrease in total migrating INs invading the cortex in
Ant1-/- animals (Figure 8C). Additionally, Ant1-/- migrating INs displayed aberrant orientation of
the leading process with 30% fewer cells oriented in the main migration path (Figure 8G and 8H).
Interestingly, Ant1-/- INs had longer trailing processes in vivo (Figure 8D), a characteristic also
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seen in wild-type INs treated with BA in vitro (Figure 8C). Neither proliferation or cell death in
the MGE or cortex were impacted by loss of Ant1-/- (Figure 8E and 8F), excluding these
mechanisms as an explanation for the reduction of cells in the mutant cortex. This suggests that a
migration phenotype is the primary cause for the IN defect in Ant1-/- embryonic cortex.
To confirm the effect of Ant1 deficiency on IN migration, Ant1-/- MGE explants were
assayed. Ant1-/- INs migrated shorter distances (~40% decrease, Figure 9A and 9B), and more
slowly (~42% decrease, Figure 9C) when compared to Ant1+/+ INs. Interestingly, Ant1-/- IN
migration was exquisitely sensitive to BA treatment, showing large reductions in IN migration
rates at doses that had no effect on Ant1+/+ cells (Figure 9C) likely due to further blocking of
mitochondrial ATP efflux through inhibition of the Ant2 isoform (Graham, Waymire et al. 1997,
Levy, Chen et al. 2000).
In contrast to the clear defects in IN migration, Ant1-/- PN migration was normal. E14.5
embryos were electroporated with pCAG-IG and cell positions assayed on E18.5. The loss of
Ant1 did not alter radial migration (Figure 10A and 10B). To further assay the migration of PN
we injected EdU to pregnant dams on E14.5 and harvested the embryos on E18.5. Labeling for
EdU (E14.5 injections mainly label outer layer neurons) and Tbr1 (a deeper layer neuronal
marker) showed normal positioning of cortical neurons between Ant1+/+ and Ant1-/- brains (Figure
10C). Together these data indicate that in marked contrast to the non-radial migration of cortical
IN, Ant1 does not appear to affect the radial migration of PNs.
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Figure 7. Migrating interneurons express Ant1
(A) Ant1 expression is detectable in migrating Dlx5/6CIG INs in explant cultures. Scale bar = 20
µm. (B) Western blot of whole brain lysate showing specificity of Ant1 antibody.
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Figure 8. Interneuron migration is reduced in embryonic Ant1 mutants.
(A) At E13.5 migrating INs (labeled by Calbindin immunohistochemistry) have not traveled as
far in Ant1-/- brains compared to Ant+/+ brains. The white arrow = leading migrating INs. Scale
bar = 200 µm. (B) Quantification of relative distance of leading cells of migrating INs normalized
to Ant1+/+ (****p < 0.0001, n = 5 individuals, 25 cells each, Mann-Whitney test). Values
represent median with interquartile range ± min/max. (C) Quantification of INs in cortex
normalized to average of Ant1+/+ ± SEM, **p = 0.004, n = 5, unpaired t-test with Welch’s
correction. (D) Ant1-/- INs in the cortex have increased trailing process (TP) length (µm ±SEM,
*p = 0.022, n = 5 individuals, 25 cells each, unpaired t-test with Welch’s correction). (E)
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Proliferation in germinal ventricular zones (VZ), indicated by Ki67 immunostaining was not
impacted by loss of Ant1. Medial ganglionic eminence (MGE) and pallium (Ctx). p = 0.3; n = 5
individuals, unpaired t-test with Welch’s correction. (F) Loss of Ant1 did not increase cell death,
indicated by Caspase 3, in the MGE and the ventral and dorsal pallium (V/D Ctx). p > 0.99, n = 5
individuals, Kruskal-Wallis, Dunn’s correction. Values represent median, 25th-75th percentile ±
min/max. (G) INs in cortex of Ant1-/- mice displayed abnormal leading process orientation.
Arrowheads = misaligned INs. Scale bar = 75µm. (H) Quantification of cortical IN leading
process orientation into quadrants: Q1, dorsal; Q2, pial; Q3, ventral; Q4, ventricular orientation.
The average percent of IN in quadrant ± SEM, ****p = 0.0001, **p = 0.0069, n = 5, ANOVA
with Sidak’s correction.
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Loss of Ant1 alters centrosome localization in migrating interneurons
To further examine the migration behaviors disrupting IN migration in Ant1-/- mutants,
we crossed these mice to Dlx5/6CIG mice to genetically label forebrain GABAergic neurons. Live
imaging of slices from Ant1-/- and littermate Ant1+/+ controls revealed ~31% decrease in
migration rates of GFP+ cells in the cortex (Figure 9E), and ~3.6 fold increase in direction
changes (Figure 9D, 9F and 9G). These data suggest an impaired ability of Ant1-/- INs to maintain
polarity. To study this further, we examined centrosome localization in MGE explant cultures. In
control INs, the centrosome localizes anterior to the nucleus or in the bleb of the leading process.
Ant1-/- INs displayed markedly aberrant centrosome positions, posterior to the leading edge of the
nucleus, or even behind the nucleus (Figure 11A and 11B). To confirm this finding, we also
assayed the localization of centrosome after BA. Similar to the findings in BA treated INs, Ant1-/INs also displayed a significant posterior positioning of the centrosome (Figure 11C and 11D).
Taken together with the increased direction changes seen after either genetic or biochemical
impairment in mitochondrial energetics, these results suggest that IN polarity is particularly
sensitive to mitochondrial perturbation.
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Figure 9. Abnormal migration by Ant1-/- interneurons.
(A) Ant1-/- INs did not migrate out of MGE explant as far as controls (16 hrs). (B) Quantification
of IN migration from explants (normalized distance ± SEM **p < 0.005, n = 6, 50 cells each,
unpaired t-test with Welch’s correction). Scale bar = 250 µm. (C) Quantification of IN migration
rates (migration rate in µm/hr ± SEM, vehicle vs. 0.5 fM BA in Ant1-/-: ****p < 0.001, n = 5, 150
cells each, ANOVA with Bonferonni’s correction). (D) Examples of migration path of GFP+ INs
in brain slice culture. Dots = start; lines = paths. Scale bar = 150 µm. (E) Ant1-/- INs in slices
have decreased migration rates (migration rate in µm/hr ± SEM Ant1+/+ vs. Ant-/-: **** p <
0.0001, n = 5, 20 cell each, unpaired t-test with Welch’s correction). (F) Ant1-/- INs display
increased direction changes per cell/hr ± SEM (p < 0.0001, n = 5, unpaired t-test with Welch’s
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correction).
(G) Frequency plot of IN direction changes; dark grey = Ant1+/+, light grey = Ant1-/-. ****p <
0.0001, ***p = 0.0006, n = 5, two-way ANOVA with Sidak’s correction.
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Figure 10. Radial migration is normal in Ant1 -/- cortices
(A) Confocal max projection of E18.5 cortices, 4 days post in utero electroporation with pCAGIRES-GFP. (B) Quantification of percent total GFP+ cells in defined cortical bin: ventricular and
intermediate zones, and 8 equal division of the cortical plate (VZ: IZ; 1-8). p > 0.5, n = 5
individuals each genotype, two-way ANOVA. Scale bar = 250 µm. (C) Representative coronal
sections from E18.5 Ant1+/+ and Ant1-/- showing Tbr1 (red) labeled cells normally positioned in
the deeper layers compared to outer positioned neurons born on E14.5 (EdU, green). All nuclei
stained with DAPI (blue) (n=3, scale bar=500 µm).
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Figure 11. Loss of Ant1 causes shift in centrosome position
(A, C) Sample images of centrosome position in INs show mislocalized centrosome in Ant1-/- INs
and BA-treated INs in vitro. Gamma-tubulin = red, nucleus = blue, cytoplasm = green. Scale bar
= 15 µm. (B, D) Scatter plot of centrosome score of Ant-/- and BA-treated INs (Grey lines =
average nuclear length). Centrosome score ± SEM; p = 0.0005, n= 75 cells each genotype, MannWhitney test, median with interquartile range ± min/max.
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Discussion
Our results reveal that migrating INs and PNs display major differences in mitochondrial
localization. During IN migration, mitochondrial localization is highly dynamic, with the highest
density of mitochondria appearing to move between the posterior trailing process, the region
anterior to the nucleus, and the cytoplasmic bleb. In contrast, during PN migration, mitochondria
are primarily restricted to the region anterior to the nucleus. We also found that inhibition of
OXPHOS drastically decreased the migration rates of INs but not PNs. These findings suggest
that INs, unlike radially migrating PNs, are highly dependent on mitochondrial ATP production.
The reduced migratory rates and increased direction changes observed in INs also suggest that the
maintenance of polarity is an energetically vulnerable process and is required for normal IN
development. These data link mitochondrial function to the prenatal development of a critical
cerebral cortical neuronal subpopulation.
Few studies have addressed mitochondrial localization and trafficking in migrating
neurons. Previous work has shown that Lis1, Tau1, and DCX, genes that cause defects in radial
migration and IN development, cause mislocalized and altered mitochondrial trafficking
(Yamada, Yoshida et al. 2009, Sapir, Frotscher et al. 2012, Khalaf-Nazzal, Bruel-Jungerman et al.
2013). Although this suggests that defects in mitochondrial localization may also impact PNs,
each of these genes also regulates microtubule dynamics. Thus in these models, it is unclear if
changes in mitochondrial localization contribute to the defects in radial migration or if these
genes have direct impacts on mitochondrial function. Our data addresses this issue by
investigating mitochondrial localization in both PN and IN populations, and by interfering
directly with mitochondrial function. Although mitochondrial dysfunction in addition to other
defects may contribute to abnormal radial migration, we provide clear evidence that INs are much
more sensitive to OXPHOS deficits.
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Mitochondrial contribution to neuronal metabolism has been largely studied in the
context of the adult nervous system, focused on how the loss of mitochondrial function results in
neurodegeneration and cell death. Recent data has emphasized the importance of mitochondrial
energetics in basic neurophysiology. For example, mitochondrial energetics are essential for
interneuron regulation of gamma oscillations that are themselves associated with cognitive
functions (Kann, Papageorgiou et al. 2014). However, little data exists on the earlier
developmental requirements for mitochondrial OXPHOS. Several studies have indicated that
regulation of mitochondrial metabolism impacts neurogenesis and differentiation (Bertholet,
Millet et al. 2013, Wang, Ye et al. 2014) but the requirement for OXPHOS during neuronal
migration had not been studied. Surin et al. suggested that glycolysis is a primary driver of
embryonic neuronal metabolism of hippocampal cultures (Surin, Khiroug et al. 2012). Since
interneurons comprise only about 6% of the neurons in hippocampal cultures (Benson, Watkins et
al. 1994), it is likely the measurements in this study were primarily representative of pyramidal
neuron metabolism. This lack of active OXPHOS in embryonic pyramidal cells thus compliments
our findings that PN migration is not impacted by OXPHOS inhibition. Our data clearly shows
that interneuron migration required OXPHOS, and suggests that distinct neuronal populations
have different metabolic requirements during development.
We found that Ant1 mutant INs exhibit changes in centrosome localization, increased
length of the trailing process, and increased direction changes during IN migration. Mitochondria
have been implicated in centrosome homeostasis in mitotic cells (Donthamsetty, Brahmbhatt et
al. 2014). Additionally, the mislocalization of centrosomes has also been observed in mice
lacking mDia1 and 3, proteins of the formin family that regulate cytoskeletal dynamics via RhoGTPases (Daou, Hasan et al. 2014). Interestingly, IN migration is disrupted in these mutants, but
radial migration is not (Shinohara, Thumkeo et al. 2012). In this model, the focus was on
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subventricular zone migration of interneurons to the olfactory bulb. Thus, it is unclear whether
there are additional phenotypic similarities exist between these models. The similarities in our
phenotype, and selective effect on INs suggest that the regulation of centrosomal position and
actinomysin contractions within the trailing process are energetically vulnerable processes and
warrant further investigation.
Patients with ASD, and particularly those with combined ASD, ID and epilepsy,
commonly have evidence of mitochondrial dysfunction (Giulivi, Zhang et al. 2010, Rossignol and
Frye 2012). The manner by which mitochondrial dysfunction contributes to these phenotypes is
generally attributed to a deficiency in meeting ongoing neuronal metabolic demands, or increased
free radical production resulting in cell death. Our data provide clear evidence for a novel final
common pathway into the pathogenesis of ASD, developmental epilepsies, and intellectual
disabilities. These clinical phenotypes associated with mitochondrial disorders may not solely
arise from energetic deficits or the formation of free radicals during later neuronal function but
may be secondary to abnormal IN development.
Materials and Methods
Mice
CD1, or Dlx5/6CIG (Stenman, Toresson et al. 2003), and Ant1-/- on a C57BL6/NJ (Ronchi,
Figueira et al. 2013) of both sexes were used as indicated. The Institutional Animal Care and Use
Committee at the Children’s Hospital of Philadelphia, Philadelphia, PA, approved all studies.
Brain explant and slice cultures
Explant and slice cultures were generated from the indicated embryonic day mouse pups
as previously described (Lysko, Putt et al. 2011).
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Treatment protocols
For inhibition of oxidative phosphorylation, explants were cultured for 24 hours in DM
with 35 mM glucose. Immediately before imaging, media was exchanged with DM with PBS
vehicle, Oligomycin (Sigma), or Bongkrekic Acid (Enzo Life Sciences). We found a strain
difference in response to treatment to BA. CD1 cells were treated with 0.5, 2.5, 5, and 50 µM BA,
while Ant1+/+ and Ant1-/- were treated with 0.5 fM BA. For glucose deprivation and inhibition
experiments, explants were cultured for 24 hours in glucose-free DMEM (Invitrogen) plus N2
supplement (Gibco) with or without 10 mM sodium pyruvate (Sigma) or 5 mM Galactose
(Sigma), +/- 2.5 µM BA. For treatment with 2-DG, explants were cultured for 24 hours with 5
mM glucose DM supplemented with 500 µM 2-DG (Sigma), with or without 10 mM sodium
pyruvate or 5 mM galactose +/- 0.5 µM BA.
Histology and immunocytochemistry
Brains of E13.5, E16, or E18.5 embryos were processed for histology and
immunohistochemistry as previously described (Lysko, Putt et al. 2011). Primary antibodies used
included anti-Calbindin D-28k (rabbit; Swant, 1:1000), Caspase-3 (rabbit; Abcam, 1:500), Ki67
(rabbit; Neomarkers, 1:300), anti-Tom-20 (rabbit; Santa Cruz, 1:500), anti-GFP (chicken:
Invitrogen, 1:2000). Secondary antibodies included goat anti-rabbit-biotin; Vector Laboratories
followed by Streptavidin-Alexa 594; Invitrogen, or anti-rabbit-Alexa 594; Invitrogen anti-chickAlexa 488; Invitrogen all at 1:2000. Nuclei were counterstained with DAPI. MGE explants were
fixed and immunolabeled as previously described (Lysko, Putt et al. 2011) using anti-Tuj1
(rabbit; Neuronal CIII b-tubulin; Covance, 1:1000), anti gamma-tubulin (mouse; 1:200 Sigma),
anti-GFP (chicken Invitrogen 1:200), or anti-Ant1 (rabbit) as primary antibodies. Mitochondria
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were labeled in migrating interneurons by staining 40 µm thick floating sections from Dlx5/6CIG
embryos and staining for Tom20, staining expressed GFP within the cytosol with anti-GFP.
Intrauterine electroporations
Embryos at either E14, or E14.5 were electroporated in utero as previously published
(Nasrallah, Cho et al. 2012) with the following constructs: pCAG-IG (Addgene 11150; 2 µg/uL),
pCAG-DsRed (Addgene 11151; 2 ug/uL), pDsRed2-mito (MitoDsRed; Clontech 632421; 0.5
µg/uL). For marking mitochondria in radially migrating neurons, and slice BA treatments,
embryos were electroporated at E14 and harvested 48 hrs later. For assessing radial migration,
embryos were electroporated at E14.5 and harvested at E18.5.
Live marking of mitochondria in vitro
To image mitochondria in migrating INs, explants from Dlx5/6CIG embryos were cultured
for 24 hrs. Prior to imaging, cells were treated with 100 nM MitoTracker® Red CMXRos
(Invitrogen) for 30 minutes in Opti-MEM (Invitrogen) with 10 mM glucose. Cells were then
rinsed with PBS and supplied with fresh DM before imaging.
Microscopy
For all experiments, time-lapse images were acquired at indicated intervals for a
minimum of 6 hours with an Olympus Fluoview (FV10i) confocal microscope at 37°C, 5% CO2.
Magnifications were as follows; 10X magnification with 2X zoom for treatment protocols in 5minute intervals, and 10X magnification in slices in 10-minute intervals. For higher resolution,
60X magnification was used for acquiring mitochondrial localization in migration INs at 10minute intervals. For slices, Z-stacks of 10 µm each were taken, capturing the full range of
detectable GFP+ cells or DsRed cells within the slice. Slices were imaged for a minimum of 5 hrs.
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Images of fixed explants cells and slices were taken on an Olympus Fluoview (FV10i) confocal
microscope at 20x magnification. Mitochondria were localized within individual cells from 40µm
brain slices by collecting 1.5µm z-stacks in using the Olympus Fluoview (FV10i) confocal
microscope at 60x magnification. Images of calbindin stained slices and were taken at 5X and
10X magnification every 5 µm for 15 µm on a Leica CTR600 fluorescent microscope.
Quantification
In all experiments, cells were selected at random using ImageJ’s grid plugin for all
experiments unless indicated otherwise. The color-profiler ImageJ plugin was used to generate
plots of fluorescence units. For fixed cells, mitochondrial area was calculated by thresholding
images using ImageJ’s auto-local thresholding plugin (for invitro culture, Bernsen method, 15
pixels), or by color thresholding images for overlapping green and red pixels (for cells in fixed
slices). Thresholded images were analyzed using the particle analyzer plugin to calculate
mitochondrial area in subcellular regions. The distance of migration along the cortex of the 25
leading cells was measured as a percentage of the distance between the striato-cortical notch and
dorsal cortical curve, and normalized to the average distance of wild-type littermates. Relative
Migration Distance for explants was calculated from the explant edge to the position of the 10
cells that had migrated the furthest. Values were normalized to averages of Ant1+/+ littermates.
Cell migration speed was calculated as previously published (Lysko, Putt et al. 2011). Leading
process orientation was calculated by designating cells into quadrants based on the orientation of
their leading processes. Centrosome scores were determined by defining the anterior edge of the
nucleus as zero and centrosomes positioned behind the leading edge of the nucleus as negative
values. Centrosome position was measured from the posterior of the cell and represented as a
percent of total cell length.
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Statistics.
Prism 6 software was used for all statistical analysis. Data were tested for normality
using either the K-S test or the D’Agostino & Pearson omnibus normality test. If the data were
not normal, non-parametric analysis was utilized. p < 0.05 were considered significant. All values
are represented as mean ± SEM unless otherwise indicated.
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CHAPTER 3: MANIPULATIONS OF THE MITOCHONDRIAL TRAFFICKING PROTEIN
MIRO1 IMPACTS INTERNEURON MIGRATION

Introduction
Mitochondria are complex organelles which provide energy, Ca2+ buffering, and
additional functions within the cell (Lackner 2014). Historically, the localization of mitochondria
in discreet regions of neurons generated the hypothesis that specific localization of mitochondria
is essential for neuronal physiology (Berthold, Fabricius et al. 1993, Fabricius, Berthold et al.
1993, Hollenbeck and Saxton 2005). Live-imaging of mitochondria in post-mitotic hippocampal
neurons revealed highly dynamic behaviors, exhibiting static and motile populations with both
retrograde and anterograde movement (Misgeld, Kerschensteiner et al. 2007). The discovery of
proteins involved in trafficking mitochondria provided reagents with which to test the
significance of mitochondria trafficking for cellular functions (Stowers, Megeath et al. 2002,
Brickley, Smith et al. 2005, Fransson, Ruusala et al. 2006). Manipulations of mitochondrial
transport proteins have shown that mitochondria indeed have a functional role in these regions of
mitochondrial enrichment in neurons, and play central roles in axonal branching, synaptogenesis,
plasticity and synaptic maintenance (Guo, Macleod et al. 2005, Kang, Tian et al. 2008, Courchet,
Lewis et al. 2013, Spillane, Ketschek et al. 2013). However, the importance of mitochondrial
trafficking at earlier neurodevelopmental time points, such as neuronal migration, remains
unexplored.
Studies elucidating the molecular mechanisms regulating mitochondrial trafficking have
identified several mitochondrial membrane-bound proteins that act as adaptors connecting
mitochondria to the molecular motor network within the cell (Figure 12). Atypical Rho-GTPase
(Miro), a mitochondrial membrane-bound protein interacts with Milton/GRIF/TRAK, creating an
adaptor complex that interacts with the molecular motor KIF5, allowing for anterograde
movement of mitochondria in neurons (MacAskill, Brickley et al. 2009). Miro and TRAK also
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facilitate the linkage of mitochondria to dynein to drive retrograde migration (van Spronsen,
Mikhaylova et al. 2013). Syntabulin has also been shown to act as an adaptor to facilitate
interactions between KIF5 and mitochondria for anterograde movement in neurons (Cai, Gerwin
et al. 2005), while the proteins FEZ1 and RanBP2 have been suggested as potential candidates
(Cho, Cai et al. 2007, Fujita, Maturana et al. 2007). Although these molecular adaptors
facilitating mitochondrial movement have been identified, the mechanism of mitochondrial
pausing or docking is not completely understood. Calcium binding to the EF hand domains of
Miro1 result in the pausing of mitochodria either by resulting in the dissociation of TRAK
proteins from KIF5 (Macaskill, Rinholm et al. 2009) or causing the dissociation of KIF5 from
microtubules (Wang and Schwarz 2009). The protein syntaphilin has been identified as an
additional regulator for mitochondrial docking, acting as an anchor to bind mitochondria to the
microtubule network (Chen and Sheng 2013).
We previously described unique and distinct mitochondrial localization behaviors in two
migrating neuronal populations: radially migrating projection neurons (PNs) and tangentially
migrating interneurons (INs). Mitochondria in migrating INs are much more dynamic in their
localization behaviors compared to their PN counterparts (Figure 3). Mitochondria move
cyclically during the migration process, moving from anterior to the nucleus, outward into the
leading process thickening, and back to the trailing process. We also found that deficits in
mitochondrial oxidative phosphorylation selectively disrupted IN migration, while leaving PN
migration intact. We hypothesize that IN migration will also be more sensitive to alterations to
mitochondrial trafficking compared to the radial migrations of PNs. To test this hypothesis, we
manipulated Miro1 due to its localization on mitochondria and its role in mitochondrial
trafficking. (Fransson, Ruusala et al. 2006, Macaskill, Rinholm et al. 2009, MacAskill and Kittler
2010) (Figure 12).
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Figure 12. Proteins involved in mitochondrial trafficking
(A) MIRO, a mitochondrial membrane-bound protein, with its binding partner GRIF/TRACK,
attaches mitochondria to the molecular motor protein KIF5, allowing mitochondria to move along
the microtubule network. (B) Syntabulin, FEZ1, and RanBP2 are also candidate proteins for
mitochondrial adaptors. (C-E) Binding of calcium to MIRO EF-motifs results in stopping of
mitochondria by preventing association of KIF5 with microtubules, TRAK association with
KIF5, or by tethering with Syntaphilin.
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We utilized a dominant negative form of Miro1, M1K208, which contains paired
mutations at its EF binding domains, sites of calcium binding. The expression of this construct in
hippocampal cells has been shown to impact calcium-dependent mitochondrial trafficking in vitro
by preventing calcium-dependent localization to specific parts of hippocampal neurons
(Macaskill, Rinholm et al. 2009). As we had observed selective localization of mitochondria to
particular regions of interneurons, we chose Miro1 due to its selective impact on mitochondrial
trafficking without interfering with vesicular transport (Fransson, Ruusala et al. 2006, Macaskill,
Rinholm et al. 2009, MacAskill and Kittler 2010).
We find that IN migration rate is subtly impacted by the expression of a dominant
negative form of Miro1. Overexpression of this dominant negative construct in INs in vitro does
not impact migration rate. However, these cells exhibit a decrease in progressive movement, and
change directions more frequently compared to controls. This reduces their ability to invade the
cortex in embryonic brain slice culture. Interestingly, we found subtle defects in radially
migrating PNs in vivo, suggesting that certain aspects of mitochondrial trafficking may play a role
in this process. This data supports a model in which changes in mitochondrial behavior and
physiology disrupts neuronal migration, with more severe deficits seen in IN migration,
elucidating a potential mechanism for the connections between mitochondrial disorders and
neurodevelopmental diseases of the cortex.
Results
Expression of a dominant negative Miro1 alters IN migration behavior
Expression of Miro1 in INs was confirmed by western blot of the ganglionic eminences
at E14.5, which include migrating INs. Mouse anti-Rhot-1 antibody detected protein in E14.5
whole brain and the embryonic striatum (Figure 13). We then tested our expression constructs to
determine if overexpression of Miro1K208 (M1K208) would impact mitochondrial localization in
3T3 cells. We observed perinuclear localization compared to controls that was not seen in
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overexpression of wild-type Miro1 (M1) (Figure 14). This correlated with previous results
(Fransson, Ruusala et al. 2006).
We then utilized our M1K208 construct to test if mitochondrial localization has an
impact on the tangential migration of migrating INs from explant cultures. Migration rates were
not significantly affected by overexpression of M1K208 or M1 (Figure 15). There was an
extreme effect on the directionality of migration; cells overexpressing Miro1K208 resulted in an
increase in direction reversals in migrating cells (GFP: 0.41 ± 0.12; M1K208: 2.1 ± 0.24;
direction changes per cell ± SEM, p < 0.01). This was not seen in cells overexpressing wild-type
Miro1 (Figure 15). The consequence of this effect resulted in less outward migration from the
explant as compared to GFP controls (Figure 15).
To test if this migration phenotype impacted the ability of Miro1K208 electroporated INs
in the context of a complex environment, we utilized whole brains slice electroporation and
culturing techniques. The MGE of brain slices from E12.5-E13.5 embryos were electroporated
with M1K208 and pCAG-IG and cultured to allow neurons to reach the cortex. Fewer total
electroporated cells in Miro1K208 slices invaded the cortex compared to controls (GFP: 20 ± 2,
M1K208: 7 ± 2, percent of total electroporated cells reaching cortex ± SEM, Figure 16). This
suggests that the increased direction changes of Miro1K208 cells indeed reduce the ability of
cells to reach the cortex.
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Figure 13. Miro1 protein is detected in E14.5 striatum
(A) Miro1 is detected in E14.5 whole brain and E14.5 striatum, lanes (L) 1 and 3. L1: E14.5
whole brain (WB), L2: WB lysate 3, L3: Striatum, L4: Striatum lysate, L5: L6: L7: L8: COS cells
transfected with pRK5HA-Miro1-V13-myc.
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Figure 14. pCAG-IG-Miro1K208 expression in 3T3 cells results in perinuclear localization
of mitochondria.
(A-H) Representative images of transfected, fixed 3T3 cells marking mitochondria (Tom20,
Red), cytosol of transfected cells (GFP, green) and nuclei (DAPI, blue) in control pCAG-IG (AD), pCAG-IG-Miro1 (E-H) and pCAG-IG-Miro1K208 (I-K). Dotted lines indicate peripheral
edges of transfected cell with mitochondria in control, whereas mitochondria are reduced in those
areas with pCAG-IG-Miro1K208.
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Expression of dominant negative Miro1 does not alter gross mitochondrial localization
behavior
We then wanted to determine if there were observable changes in IN mitochondrial
localization with Miro1K208 expression. We have previously observed clustering of
mitochondria in distinct regions in INs migrating in vitro (Figure 3). INs that had mitochondrial
localization correlating to stage of migration (stage 1: tapered leading process with mitochondria
concentrated anterior to the nucleus, stage 2: clear cytoplasmic thickening of the leading process
with mitochondria concentrated in the thickening, and stage 3: A clear trailing process with
corresponding mitochondrial clustering) were scored as normal, and INs in which mitochondria
were diffusely distributed, or had mitochondria localized out of synchrony with cell stage were
scored as abnormal.
This proved difficult, as electroporated cells are often located further inward from the
explant edge, which can reduce antibody penetration. Although a greater number of cells should
be assessed, gross mitochondrial localization did not appear to differ significantly between
control and Miro1K208 expressing cells (GFP: 87 ± 1%; M1K208: 84 ± 3%, % cells with
normally localized mitochondrial pattern ± SEM, Figure 17). Although gross localization
appeared normal, it is possible that Miro1K208 has more subtle effects on mitochondrial
trafficking and localization. To determine if Miro1K208 expression altered mitochondrial
trafficking rates during migration, we co-electroporated p-CAG-mito-DsRed with p-CAG-GFP
and M1K208 constructs into MGE explant culture and examined migrating cells. The detection of
the rapid migration behaviors of mitochondria in INs requires imaging techniques with both highresolution optics, and rapid image capturing rates. First, we assessed imaging capabilities on
spinning disk microscopy. We found this required laser powers that could be traumatic to cells,
often resulting in cells that did not migrate. In cells imaged, mitochondria exhibited both
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Figure 15. Expression of Miro1K208 increases direction changes in migrating INs in vitro.
(A,B) Migrating interneurons electroporated with (A) GFP, or (B) M1K208. White arrows
indicate direction changes of the cell. (C, D) Migration tracings of 50 cells each of (C) GFP and
(D) M1K208 cells. (E) Quantification of turns per cell for GFP, M1, M1K208 cells n= 3
replicates, minimum 150 cells total, p <0.01. (F) Migration rate of GFP, M1 and M1K208
expressing cells. n= 3 replicates, minimum 150 cells total, ANOVA with Bonferroni correction,
ns.
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Figure 16. Miro1K208 expression reduces invasion of migrating INs into the cortex in slice
culture
(A, B) MGE of slices from E 12.5-13.5 embryos focally electroporated with (A) pCAG-IG, or
(B) pCAG-IG-Miro1K208 (M1K208). Scale bar: 300 µm. (C) Quantification of the percent of
total electroporated INs that invaded the cortex. GFP, n = 20, M1K208, n = 9. (***, p<0.001,
unpaired t-test with Welch’s correction)
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Figure 17. Expression of Miro1K208 in migrating interneurons does not cause gross
mitochondrial localization defects.
(A) Representative INs electroporated with GFP or M1K208-GFP. Scale bar: 15 um. (B) Percent
of cells with normal distribution of mitochondria n = 8 GFP, 3 M1, 6 M1K208. Minimum of 75
cells assessed each construct. (C, D) Imaging of cells co-electroporated with GFP or M1K208 and
mtDsRed, 30 sec. per frame. In (C), white arrows in the right panel follow a trackable
mitochondria. (E) Mitochondrial velocity in GFP and M1K208 electroporated interneurons. n=15
GFP cells, n=8 M1K208 cells.
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anterograde and retrograde movement of mitochondria within the leading process (Figure 17C
and 17D). Preliminary data suggests mitochondria migration rate is not impacted by expression of
Miro1K208 (Figure 17E). However, considering these cells were not migrating normally, it is
unclear if the mitochondrial trafficking behavior observed matches what would occur during
normal migration. Additionally, co-electroporation efficiency with mito-DsRed and pCAGIG/Miro1K208 was too low to generate enough cells to assess mitochondrial trafficking behavior
adequately.
As an alternative method, we imaged migrating neurons with two-photon microscopy.
We did find that this imaging system was capable of capturing migrating interneurons with high
frequency (as high as 15s intervals) for long periods of time without compromising cell migration
and cell health (Figure 18C). However, mito-DsRed was not detectible in this system (Figure
18A, 18B). Mitotracker Red was detectable in this system and allowed for high-resolution
tracking of mitochondria. However, electroporated cells are often farther away from the outer
edge of the migrating cells and the dye does not penetrate into the explant sufficiently for
adequate signal detection. We then examined whether expression of Miro1K208 would interfere
with the radially directed migration of PN neurons. Embryonic day 14.5 embryos were
electroporated with M1K208, or control constructs. After 4 days, there were increased numbers of
Miro1K208 cells in the VZ/SVZ of the cortex, but this was not statistically significant (Figure
19B). We then assessed PNs at P15, after which PN migration is complete. Interestingly, although
Miro1K208 cells do reach outer layers, there is a subtle defect, with a 36 percent increase of
Miro1K208 cells in bin 7 and a 23 percent decrease of Miro1K208 cells in bin 8 compared to
controls (Figure 19D).
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Figure 18. Imaging techniques examining mitochondria
(A) Two-photon image of radial cortical cells electroporated with GFP and MitoDsRed. The
filters are unable to pick up the signal from DsRed, (B) clearly seen in fixed tissue from coelectroporated brains. (C) Two-photon live imaging of Dlx5/6-Ires-GFP interneurons stained with
MitoTracker red displaying normal migratory behavior. Cells were imaged in a single plane,
every 30 seconds. Scale: 25 µm.
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Discussion
We found the expression of Miro1K208 compromised interneuron migration by
disrupting progreessive movement of migrating cells. This disruption resulted in an inability of
M1K208 expressing interneurons to reach the cortex in cultured embryonic brain slices.
Interestingly, this migration phenotype was observed during the interference of oxidative
phosphorylation in migrating INs (Figure 5 and 6).
Due to the similarities between the phenotypes, it would be important to determine if the
dominant negative form of Miro1 has any effect on mitochondrial function. A limitation of our
experimental model is the difficulty with which to measure the mitochondrial function and
respiration in migrating interneurons. The XF24 Extracellular Flux Analyzer (Seahorse
Bioscience, Billerica, MA), although uniquely capable of measuring active respiration in cell
culture wells rather than cell suspensions, often requires large numbers of purified cells (Wu,
Neilson et al. 2007). Multiple attempts to measure the respiration of migrating interneurons from
explants utilizing this system were unsuccessful (data not shown). Explant cultures also contain a
mixed population of dividing neural progenitor cells, which likely have a different metabolic
profile compared to the oxidative phosphorylation of migrating INs. Additionally, electroporation
of the MGE is relatively inefficient, and very few cells expressed introduced constructs
(approximately 50-200 cells per explant). An alternative would be to express fluorescent ATP
sensor constructs targeted to the mitochondria versus cytosol (Tarasov and Rutter 2014).
However, these tools have not been validated in interneurons which are a highly complex cell
type to electroporate and image. Although we can infer that the impact on mitochondrial ATP
production is likely intact due to the normal interneuron migration observed in M1K208
expressing INs (Figure 15F) and it has been shown that Miro1K208 does not impact
mitochondrial function in rat hippocampal neurons (Macaskill, Rinholm et al. 2009), we cannot
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Figure 19. Miro1K208 has subtle effects on radial migration
(A) Fluorescence immunohistochemistry of radially migrating pyramidal neurons (PNs) 4 days
after in utero electroporation. (B) Quantification of percent of total electroporated cells in cortical
bins. n = 5 for control, and Miro1k208. Scale bar is 100 µm. 2-way ANOVA with Sidak’s
correction. (C) Fluorescence immunohistochemistry of radially migrating pyramidal neurons at
P15. (D) Quantification of percent of total electroporated cells in equally divided cortical bins. n
= 5 for control, and Miro1k208. 2-way ANOVA with Sidak’s correction. (A, C) Scale bar is 100
µm.
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definitively conclude that M1K208 has no effect on ATP production from oxidative
phosphorylation.
Mitochondria express a dynamic migratory pattern within migrating INs (Figure 3). It is
unclear if this subcellular localization of mitochondria plays an important role in IN migration.
Although expressing a dominant negative form of M1K208 in hippocampal neurons interferes
with mitochondrial trafficking (Macaskill, Rinholm et al. 2009), we were unable to confirm the
effect of M1K208 on mitochondrial dynamics in migrating interneurons. Imaging migrating
neurons requires a balance between adequate optical resolution, adequate laser power, and high
PMT sensitivity. The movement of migrating INs is a process occurring over minutes, while
mitochondria can move rapidly in seconds. Often the laser power, z-stack resolution and highfrequency imaging intervals to capture mitochondrial movements resulted in cells that would no
longer migrate (Figure 17C and 17D). Additionally, the process of transporting INs to imaging
facilities also resulted in cells that would not appear healthy (collapsed leading processes and
absence of migration).
Although our preliminary analysis did not detect changes in mitochondrial migration
rates, these cells were not exhibiting normal migration behavior and may have been
physiologically compromised, which can alter mitochondrial behavior (Chang and Reynolds
2006). However, we did observe mitochondria within an extended trailing process of a
Miro1K208 expressing cell, which was not seen in a GFP cell with similar morphology (Figure
17D). The continued presence of mitochondria in this extended trailing process may contribute to
the persistence of this structure, but significantly more cells need to be assessed.
Miro1K208 may alter the percent of moving mitochondria, alter behaviors such as
pausing and docking, or prevent the exclusion mitochondria from certain regions. The imaging
methodology utilized to measure mitochondrial migration did not have sufficient resolution to
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assess these behaviors. Thus, the evaluation of mitochondrial trafficking in cells exhibiting
normal migration behaviors would be required to categorize the effect of Miro1K208 on
mitochondrial trafficking behaviors in migrating neurons.
Two-photon microscopy is ideal for reducing photo-toxicity, and appears optimal for
assessment of mitochondria in migrating cells (Figure 18), and we were able to capture GFP
positive interneurons treated with mito-tracker at high time resolution without compromising cell
migration. However, limited dual excitation of mito-dsred and M1K208-GFP prevented our
ability to detect mitochondria in co-electroporated cells (Figure 18) utilizing this imaging
methodology. Mito-tracker penetration into electroporated explants is insufficient to reach cells
expressing GFP constructs (data not shown). Utilizing ultra-resolution microscopy, or better
filters may give the resolution and excitation required to capture subtle changes in mitochondrial
dynamics in these cells. Additional genetic tools may also facilitate this process. Genetic mouse
models are available with fluorescently tagged mitochondria Thy1-mitoCFP, which would allow
for tracking of mitochondria in electroporated cells. (Misgeld, Kerschensteiner et al. 2007).
A Miro1 knockout would provide a valuable tool as well. This particular mouse model
exists, and although the gross structure of these mutant cortices was normal in Miro1 knockouts
(Nguyen, Oh et al. 2014), interneurons were not assessed. MGE explant cultures from Miro1-/Dlx5/6Cre-Ires- GFP paired with vital mitochondrial dyes would allow examination of the effects
of Miro1 loss on mitochondrial dynamics in pure cultures of Miro1 deficient migrating
interneurons would be useful. If this genetic tool were utilized, experiments assessing interneuron
migration would have to be performed, as our prior data was utilizing a dominant negative form
of the protein rather than a genetic knockout.
An alternative method for addressing this experimental challenge would be to manipulate
other aspects of the mitochondrial-trafficking protein network. The knockdown of Syntabulin
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results in a significant reduction of anterograde migration of mitochondria and reduced
mitochondria in distal axonal processes (Cai, Gerwin et al. 2005). However, this protein has been
associated with the movement of vesicles within neurons (Su, Cai et al. 2004). Knockdown of
APC slows Miro/Milton anterograde trafficking of mitochondria in multiple cancer cell lines
(Mills, Brocardo et al. 2016). However, APC also as additional functions in microtubule
dynamics and thus experiments must be conducted to separate the consequences of these two
functions of APC. Overexpression of Syntaphilin results in immobilization of mitochondria in
axonal mitochondria, and is a candidate to test a more drastic impact on mitochondrial movement
in migrating INs (Chen and Sheng 2013).
Confirming abnormal mitochondrial localization behavior was not successful in this
study. Data from Macaskill et al. suggests that M1K208 expression interferes with the ability for
hippocampal neurons to target their mitochondria during neuronal firing (Macaskill, Rinholm et
al. 2009). Fixed cells electroporated with Miro1K208 and Miro1GFP had grossly normal
mitochondrial localization, suggesting that Miro1K208 may cause subtler impact on
mitochondrial localization or dynamics in interneurons. Conclusive evidence of altered
mitochondrial dynamics requires live-imaging of mitochondria within electroporated cells, and
although preliminary data suggests that mitochondrial migration rates are not affected, higher
time resolution studies are required to fully examine changes in mitochondrial dynamics in
migrating interneurons.
We previously found that migrating PNs were not impacted by manipulations in
oxidative phosphorylation (Figures 6 and 10). However, we did not assess PN at later stages
(P15). The alteration of mitochondrial trafficking having subtle impacts radial migration provides
evidence that radial migration can be effected by manipulations in mitochondria. Radially
migrating PNs may require mitochondria to be persistently localized in the anterior perinuclear
region for local ATP or Ca buffering. Live imaging experiments would provide additional
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information if changes in mitochondrial trafficking would be detectible, however adequate time
and spatial resolution in slice culture is likely to be a significant challenge. Targeting a protein
such as Syntaphilin, which would result in a more severe impact on mitochondrial trafficking
behavior may cause a more pronounced phenotype that may be more easily detected.
Although we were unable to confirm disruption of mitochondrial localization with our
available resources, this preliminary work is consistent with a model in which migrating
interneurons are more sensitive to mitochondrial perturbations compared to their radially
migrating counterparts.

Material and Methods
Constructs
pRK5HA-Miro1k208-GFP, Miro1V13-myc and Miro1-GFP plasmids were kindly
provided by Drs. P. Appenström and G. Hajnoczky. These base constructs were used to construct
pCAG-IG-Miro1 and pCAG-IG-Miro1K208 by PCR cloning. The coding sequences of Miro1
and Miro1K208 with the following primers: FW: accg gaattc cacc atgaagaaagacgtgcggatcct. R:
acttca acgcgt tcacttgtcatcgtcatccttgtaatctcgctgtttcaataatgctttgtacatagc. Product was inserted into
linearized pCAG-IRES-EGFP by utilizing EcoR1 and MluI sites. Construct fidelity and
mutations were confirmed by sequencing.
Cell culture
3T3 or Cos cells were transfected with indicated plasmids utilizing Fugene 6 (Roche),
and cultured for 2 days prior to fixation or protein isolation.
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Mice
CD1 mice were used for all experiments. Both sexes were used for experiments. The
Institutional Animal Care and Use Committee at the Children’s Hospital of Philadelphia,
Philadelphia, PA, approved all studies.
Western Blot
Protein was obtained from E14.5 whole brain, micro-dissected striatum, 3T3 cells, and
COS cells transfected with pRK5HA-Miro1V13-myc as a positive control. Protein was run on a
10% SDS page gel. Blots were probed with mouse-anti-Rhot1 (Sigma) at 1:1000, and goat-antimouse-HRP (Biorad) at 1:2000, and developed with ECL (Thermoscientific).
Brain explant culture
Explants were generated from at embryonic day 14.5. Embryonic brains were dissected
on ice cold HBSS (Sigma), embedded in 4% low-melt agarose (Lonza) and sliced into 250 µm
thick sections. Explants were then electroporated with constructs at a concentration of 3 ug/uL.
The MGE was then microdissected in DFS (DMEM:F12; Invitrogen, with 10% fetal bovine
serum, 40 mM Glucose, 40µM L-Glutamine) and cut into ~200 µm cubes, and were placed in a
gel of 35% acidic collagen (0.0035 N acetic acid in rat tail collagen; BD Pharmogen), 50%
matrigel (BD Pharmogen), 15% DM (DM; glucose free DMEM (Invitrogen), N2 supplement
(Gibco), +/- Glucose as indicated) and 5 mM HEPES. Explants and gel incubated at for 30
minutes at 37 °C 5% CO2 to set, and DM medium added.
Brain slice electroporation and culture
Brains were dissected on ice cold HBSS (Sigma), embedded in 4% low-melt agarose
(Lonza) and sliced into 250 µm thick sections on a Leica VT1200S vibratome, and placed on
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filter inserts (Millipore). Slices were covered multiple layers of matrigel collagen mixture (as
previously described) incubated at 37 °C 5% CO2 for 20 minutes to recover. Slices were then
placed in pressure injected with ~3 µL of DNA at a concentration of 3 µg/µL and electroporated
using an NEPA21 electroporator. Slices were then cultured for 4 days in DM medium before
fixation with 4% PFA for 1 hr RT and imaged via confocal imaging.
Immunohistochemisry and Immunocytochemistry
3T3 cells were fixed for 10 mins at RT in 4% paraformaldehyde (PFA), and rinsed in
PBS buffer, and permeabilized for 20 minutes with 0.04% Triton. MGE explants were fixed in
for 12 minutes in 4% PFA and PHEM (PIPES, HEPES, EGTA, and MgSO4) buffer at 37 °C.
After washing in 1x PBS, explants were stored in 1x PBS at 4 °C until staining. For staining,
explants were treated with 1:50 collagenase (Roche) for 15 minutes, permeabilized for 15 minutes
with 0.04% Triton. Explants were blocked with 10% normal goat serum for 1 hour at RT.
Explants and 3T3 cells were incubated overnight at 4ºC with primary antibodies anti-Tom20
(rabbit; Santa Cruz, 1:750), anti-GFP (chicken Invitrogen 1:200).
Intrauterine electroporations
Embryos at E14.5 were electroporated in utero as previously published (Nasrallah, Cho et
al. 2012) with pCAG-IG (Addgene 11150; 2 µg/uL) or pCAG-IG-Miro1K208. Embryos were
electroporated at E14.5 and harvested at E18.5, or at P15. Pups at P15 were anesthetized and
perfused with 4% PFA and fixed overnight at 4ºC. Brains were frozen and sectioned at 30 µm
(E14.5) and 12 µm (P15) sections. For assessment of two-photon microscopy for imaging
mitochondria, embryos were electroporated with pCAG-IG, and MitoDsRed, and harvested 24
hours later.
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Microscopy
Time-lapse images were acquired at indicated intervals for a minimum of 6 hours with an
Olympus Fluoview (FV10i) confocal microscope at 37°C, 5% CO2 at 10X magnification with 2X
zoom for treatment protocols in 5-minute intervals and 10X magnification in slices in 10-minute
intervals. Images of fixed explants INs and IUEP brain sections were taken on a Leica CTR600
fluorescent microscope. Spinning disk microscopy, Z-stacks were at 2-micron intervals with
captures every 2 minutes. Two-photon microscopy, with z-stacks of 2.5 microns.
Quantification
Cell migration characteristics.
Cell migration speed was calculated as previously published (Lysko, Putt et al. 2011).
Cells were selected at random and followed during the live imaging process using ImageJ Manual
Tracking plugin. For in vitro experiments, a minimum of 25 cells per n was followed.
To assess cortical migration, the cortical thickness was divided into 10 bins. For E18.5,
bin 1 consisted of the VZ/SVZ recognized by DAPI staining, bin 2 consisted of the cell-sparse IZ,
and the remaining cortical plate was divided into 8 bins. For P15, the cortex was equally divided
into 10 equal bins. Up to three 100 µm alternating regions of interest spanning the thickness of
the cortex per section and a minimum of 3 sections per individual were counted. The percent of
total electroporated cell per bin was calculated to account for differences in transfection
efficiency.
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Mitochondrial localization and tracking
Mitochondrial localization was quantified as previously described (Material and
Methods, Chapter 1). Mitochondria that were distinguishable were tracked utilizing ImageJ
Manual Tracking plugin.
Statistics
Prism 6 software was used for all statistical analysis. Data were tested for normality using
either the K-S test or the D’Agostino & Pearson omnibus normality test. If the data were not
normal, non-parametric analysis was utilized. p < 0.05 were considered significant. All values are
represented as mean ± SEM unless otherwise indicated.
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CHAPTER 4: CONCLUSIONS / FUTURE DIRECTIONS

Our data reveals a fundamental difference between the requirements for non-radial versus
radial migration in metabolism and has implications in our understanding of the impact of
mitochondrial dysfunction to cause neuronal deficits of developmental origin. Contrary to the
hypothesis that embryonic neurons are glycolytic in their metabolism (Surin, Khiroug et al.
2012), we show conclusive evidence that mitochondrial oxidative phosphorylation is essential for
interneuron migration. Inhibition of mitochondrial OXPHOS resulted in decreased migration
rates, increasing direction changes and abnormal centrosome positioning. Cells also exhibited
morphological changes including increased trailing process length and life as well as decreasing
leading process length, branch length, and leading branches per cell. Collectively, these changes
contributed to a reduction in the ability of interneurons to migrate into the cortex.
Mitochondrial OXPHOS impacts IN leading process behavior
In our studies, inhibiting OXPHOS pharmacologically results in decreased leading process
length and decreased branching (Figure 5 I-K), a potential indication of leading process and
branch instability. A balance of leading process dynamics versus stabilization and appropriate
branching behaviors are required for normal interneuron migration (Kappeler, Saillour et al.
2006, Martini, Valiente et al. 2009, Gopal, Simonet et al. 2010, Lysko, Putt et al. 2011).
Interneuron leading process dynamics and leading process branching are due to modulation of the
actin and cytoskeleton network (Lysko, Putt et al. 2014). Thus, investigating the specific effects
of pharmacologic and genetic OXPHOS inhibition on the cytoskeletal network is a logical
direction of future research.
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Dynamic and stabilized microtubules have been assessed in migrating interneurons with
acetylated and tyrosinated tubulin (Gopal, Simonet et al. 2010, Lysko, Putt et al. 2014). In
migrating interneurons stabilized microtubules are localized throughout the leading process shaft,
while dynamic microtubules are more prominent within the trailing process, leading process tip,
and newly forming branches (Lysko, Putt et al. 2014). Preliminary experiments indicate that
acetylated tubulin in BA treated interneurons does not extend down to the distal leading process
compared to control cells (Figure 20A-C). Although tyrosinated tubulin remains to be evaluated,
this reduction of acetylated tubulin warrants further examination of microtubule network
regulators. Several microtubule-associated proteins (MAPs) known to contribute to microtubule
stability (Tau, DCX, APC, and MAP2) and are expressed along the leading process in migrating
interneurons (Lysko, Putt et al. 2014). Of these MAPs we will evaluate Tau, DCX and APC,
MAPs that have been linked to mitochondrial behavior, as potential candidates for evaluating
microtubule regulation in OXPHOS-inhibited interneurons. We will also discuss DISC1, a
protein known to modulate microtubule stability through its interactions with MAP1 (Morris,
Kandpal et al. 2003).
Tau has been implicated in the regulation of mitochondrial morphology in radially migrating
neurons. Although examination of Tau localization in OXPHOS-inhibited cells is a relevant
experiment to conduct, knockdown or genetic ablation of Tau results in abnormal radial migration
(Sapir, Frotscher et al. 2012). We did not observe and deficits in radial migration in our previous
pharmocologic and genetic interference of OXPHOS, and thus Tau localization and function may
not be impacted. Although loss of DCX in migrating interneurons results in decreased branch
stability, migration speeds are not significantly impacted. Thus interpretation of any changes in
DCX in OXPHOS may not directly contribute to the profound migration phenotype we see in INs
(Kappeler, Saillour et al. 2006).
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The MAP adenomatous polyposis coli (APC) has been implicated in mitochondrial
trafficking in colorectal cancer cells (Mills, Brocardo et al. 2016). Additionally, APC’s regulation
of the microtubule network is distinct between radial and tangentially migrating cells; APC
regulates microtubule (MT) dynamics via the microtubule severing protein p60-katanin in INs,
but not PNs (Eom, Stanco et al. 2014). APC deficient cells have increased expression of and
phosphorylation of p60-katanin. This subsequently results in increased p60-katanin activity, and
increased MT severing, thus decreasing MT stability. Considering our interneuron selective
deficit with OXPHOS inhibition, APC is the most attractive candidate of the aforementioned
MAPs to evaluate in our experimental models.
DISC1, a protein involved in multiple cellular processes, supports microtubule stabilization
by interacting MAP1A and the centrosome (Morris, Kandpal et al. 2003). DISC1 knockdown
results in long leading process, the opposite of our phenotype. However, DISC1 is expressed in
the leading process tip and the trailing process, and it is possible that its functions are distinct in
these two regions. Additionally, DISC1 has also been shown to interact with mitochondrial
trafficking adaptors and mitofusins (Norkett, Modi et al. 2016). Thus, considering our distinct
trailing process phenotype, DISC1 is still of interest for evaluation in this region.
One way to assess the contribution of microtubule instability within OXPHOS-inhibited cells
is through pharmacologic stabilization of microtubules. Several inhibitors of microtubule
catastrophe have been tested in migrating cancer cell models, such as indanocine, which results in
widespread tubulin acetylation, and thus low levels of this inhibitor may reduce leading process
deficits seen BA-treated cells (Kapoor and Panda 2012). This will allow us to evaluate the
contribution of leading process instability to the migration phenotype we observed. In addition to
microtubule stabilization, microtubule polymerization behaviors may by altered in OXPHOSinhibited cells. In addition to evaluation of tyrosinated tubulin in fixed OXPHOS-inhbited cells,
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live-imaging experiments allowing for real-time analysis of microtubule dynamics should be
conducted. Live time-lapse fluorescence microscopy of EB3, a microtubule endcap protein,
would allow higher resolution evaluation of microtubule polymerization during active migration
and leading process branching behaviors (Steinecke, Gampe et al. 2014).
Interneuron branching can be characterized into branched leading process and interstitial
branches that emerge from the leading process (Gopal, Simonet et al. 2010, Lysko, Putt et al.
2011). More in-depth analysis of branching behavior can be pursued in our model of OXPHOS
inhibition to better characterized branching deficits observed into interstitial branching versus
leading process splitting. This information will also contribute to the characterization of deficits
in branch initiation and branch persistence. Branching along the leading process is initiated by
filamentous actin protrusions being stabilized by tyrosinated tubulin (Lysko, Putt et al. 2014). We
have preliminary data suggesting that inhibition of leading process phalloidin protrusions are
reduced (Figure 20C and 20D). Although we did not assess tyrosinated tubulin within the leading
process, it is likely that the absence of the actin protrusions along the leading process in treated
cells would concurrently result in the absence of tyrosinated tubulin associated with these
transient leading process structures. Further investigations into why these actin protrusions are
absent from the leading process of OXPHOS-inhibited cells and their significance to changes in
branching dynamics should be investigated.
In post-migratory neurons, axon branches originate from actin patches that proceed
Arp2/3 targeting and actin filopodia formation (Spillane, Ketschek et al. 2011). In sensory axons,
this is associated with localized areas of PI3K activity and linked to actively respiring
mitochondria (Ketschek and Gallo 2010, Courchet, Lewis et al. 2013). Although the localization
of Arp2/3 in migrating interneurons is unknown, it is a strong candidate to assess if the initiation
of leading process filipodia formation is dependent on oxidative phosphorylation. Actin filipodia
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Figure 20. Bongkrekic acid treated cells exhibit changes in acetylated tubulin and F-actin
localization
(A) Representative immunofluorescent images of in vitro cultured MGE cells treated with BA.
DAPI = blue, BIII-Tubulin = green, and acetylated tubulin = red. (B). Quantification of the
percent of total LP length expressing acetylated-tubulin. N≥ 34 cell each. (C) Distribution of
acetylated tubulin expression in the leading process. (D-E) F-actin staining in BA-treated cells.
Note the reduced F-actin protrusions along the leading process of BA-treated cells. (E) F-actin is
present in the trailing process of vehicle treated cells. In BA-treated cells with normal trailing
processes, there were cells seen with no F-actin. Cells with abnormally long trailing processes
have F-actin localized to the tips, similar to the leading processes. F-actin in the leading process
tip does not appear to be impacted. (A-E) Scale bar = 10 µm.
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are subsequently stabilized by formins, like mDia, and it is thought that this protein can also
impact RhoA regulation of actin patches in axonal branching (Spillane and Gallo 2014). Indeed,
mDia has been implicated in selective defects in interneuron migration in F-actin regulation,
especially in the trailing process (Shinohara, Thumkeo et al. 2012).
F-actin at the leading tip is also thought to contribute to the splitting of the leading process
into terminal branches (Bellion, Baudoin et al. 2005, Lysko, Putt et al. 2014). OXPHOS
inhibition does not appear to effect F-actin localization at the leading process tip of migrating
interneurons (Figure 20C and 20D). More refined examination of branching behavior will
determine if interstitial branching is selectively impacted with OXPHOS inhibition. If reduced
leading process splitting is also observed, it is possible that downstream regulators of leading
process branching from the LP tip are impacted (Lysko, Putt et al. 2014).
Branch stability has been previously assessed in models of deficient migration (Gopal,
Simonet et al. 2010) by measuring acetylated versus tyrosinated tubulin in the structure of
existing branches. Although co-staining of acetylated and tyrosinated tubulin were not successful
in preliminary experiments, further analysis of acetylated tubulin within identifiable branches
seen in OXPHOS-inhibited cells will be performed.
Regulation of the cytoskeleton consists of a complex regulatory network that regulates the
nucleation, extension, stabilization, and dynamics to facilitate the drastic changes in cell
morphology observed in migrating interneurons. There are multiple potential studies to dissect
the impacts on molecular regulators of the cytoskeletal network and the importance of
mitochondria during this process. However, although preliminary data suggests changes in both
microtubule and actin exist in interneurons with OXPHOS inhibition, these changes may be
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secondary consequences to compromised polarity (reduced LP identity), or guidance signaling
rather than direct regulation of the cytoskeleton.
Cell polarity is likely impacted by Inhibition of Mitochondia OXPHOS
Both inhibition of oxidative phosphorylation and the expression of Miro1K208 resulted in
significant increases in direction changes and a loss of progressive migration that ultimately
reduced the number of interneurons migrating into the cortex (Figure 5, 6, 8, 9, 15 and 16). These
consistent abnormal migration behaviors, as well as the profound changes in trailing process
behavior, suggest that mitochondria play a key role in trailing process function and interneuron
polarity.
The trailing processes of OXPHOS-inhibited cells exhibit behaviors similar to their leading
processes: extending, retracting, and even occasionally branching (see supplemental movies in
(Lin-Hendel, McManus et al. 2016)). Further characterization of trailing process dysfunction with
OXPHOS inhibition is an opportunity for future research. The trailing process is commonly
identified by its morphological and cyclical traits; a small ephemeral cytoplasmic domain behind
the nucleus opposite to the leading process that is most clearly distinguished during
nucleokinesis, and by proteins that localize in this region when it is observed. Consistent with
previous publications, we have confirmed the tendency of mitochondria to cluster in this region
during nucleokinesis (Bellion, Baudoin et al. 2005). Molecular markers of the trailing process are
sparse: f-actin concentrates in this region during nucleokinesis, and it is a site of myosin IIB
localization (Martini and Valdeolmillos 2010). Preliminary studies examining the cytoskeletal
components of OXPHOS-inhibited cells suggest that some OXPHOS-inhibited cells with normal
morphology lack this F-actin localization (Figure 20D). Additionally, cells exhibiting abnormally
long trailing processes express characteristic F-actin localization similar to the leading process tip
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(Figure 20D). This immunocytochemical data should be confirmed with fluorescence liveimaging techniques utilizing fluorescent actin constructs such as lifeact or RFPP-UtrCH to
observe real-time actin condensation in the trailing process in OXPHOS-inhibited cells (Riedl,
Crevenna et al. 2008, Martini and Valdeolmillos 2010, Lysko, Putt et al. 2014). Additionally,
staining for proteins associated with the leading process enriched in the leading process tip, such
as cortactin or DCX would further support that elongated trailing processes in OXPHOS-inhibited
cells have more leading process characteristics (Lysko, Putt et al. 2014).
It is possible that mitochondria function within this region by providing energy for myosin
IIB phosphorylation and thus towards functional actomyosin contractions. Attempts to examine
the status of myosin IIB phosphorylation in interneurons with immunohistochemistry was
unsuccessful. Although fluorescence resonance energy transfer constructs exist to visualize
phosphorylation of myosin II regulatory light-chain in cells (Yamada, Hirose et al. 2005), they
have not been tested in interneurons. It is possible that myosin IIB localization to the trailing
processes itself is disrupted during oxidative phosphorylation, and live imaging studies utilizing
GFP-NMII mice, which express a GFP-tagged fusion protein of human myosin IIB would be a
useful tool in investigating this further (Bao, Ma et al. 2007).
The regulation of interneuron polarity during migration is poorly studied, and there are few
publications that describe phenotypes of loss of polarity in migrating interneurons. Thus, each of
these studies provides potential insight to the phenotypes observed in our studies with
manipulations of mitochondria.
Diap1/2, also known as mDia1 and 3, are Rho-regulated actin nucleators. Deficiency in
mDia1 selectively impacts interneuron migration (Shinohara, Thumkeo et al. 2012). These cells
exhibit abnormally localized centrosomes. Within these mutant neurons, F-actin condensation and
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myosin IIB localization in the trailing process are abnormal. Considering that we see an absence
of F-actin in the trailing process of some migrating interneurons treated with BA (Figure 20D), it
is possible that as in mDia knockouts, that myosin IIB localization to the trailing process is
impeded. The similarities between mDia knockouts and our model support the hypothesis that
mitochondrial-generated ATP is required in the trailing process to support its function in
migration. Another example of abnormal interneuron polarity during migration has been
demonstrated by interfering with p53/Cdk5 phosphorylation of ErbB4 (Rakic, Kanatani et al.
2015). Although these cells exhibit differing branching abnormalities, abnormal polarity of
migrating interneurons was observed. Interestingly, Cdk5 has been shown to regulate
mitochondrial fission by phosphorylation of DRP1 (Jahani-Asl, Huang et al. 2015). If
mitochondrial oxidative phosphorylation is disrupted in interneurons, it is possible that
phosphorylation of key proteins involved in trailing process function does not occur, impeding
the subsequent contraction of the trailing process to allow for appropriate nucleokinesis.
N-cadherin (N-cad), a cell adhesion molecule, is expressed along the migrating path of both
radially and tangentially migrating neurons (Kadowaki, Nakamura et al. 2007). This adhesion
molecule functions by homophilic interactions and is expressed in migrating cortical
interneurons. Fascinatingly, Luccardini et al. discovered the essential role of N-cad in
maintaining interneuron polarity during tangential migration (Luccardini, Hennekinne et al.
2013). Both overexpression of dominant negative N-cad and genetic ablation of N-cad revealed
similar abnormalities in phenotype: extended trailing processes with increased polarity reversals,
shortened leading processes, and abnormal centriole and Golgi apparatus localization.
Additionally, myosinIIB localization was impaired with expression of a dominant negative N-cad
construct in vitro. Previous studies have also shown that changes in N-cad signaling can result in
changes in the primary cilium (Luccardini, Leclech et al. 2015). There are striking similarities to
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the phenotypes observed in this work in comparison to interneurons undergoing inhibition of
oxidative phosphorylation. It is possible that mitochondria play a key role in normal N-cadherin
signaling in addition to potential effects on myosinIIB localization and phosphorylation.
The N-cad pro-migratory signaling cascade in interneurons not fully elucidated. One
proposed pathway is via activation of MAPK/ERK signaling, and potentially regulating
downstream RhoA activity via Rac1 and Cdc42 activation of p190RhoGAP. RhoA is known to
play a role in interneuron migration (Katayama, Imai et al. 2013). Interestingly RhoA and formins
have been shown to regulate the distribution mitochondrial localization (Minin, Kulik et al.
2006), providing a link between mitochondrial localization and known functional regulators of
interneuron migration that are associated with the trailing process.
Proteins directly responsible for maintaining cell polarity and centrosome positioning are
poorly studied in interneurons. Studies on polarity complexes in neurons have emphasized axon
and dendrite specification in post-migratory neurons. The Par3/Par6/aPKC complex is thought to
affect neuronal polarization by down-regulation of microtubule affinity regulating kinase MAPK2
and by activation of Rac1 via Cdc42 (Chen, Wang et al. 2006). Studies investigating genetic
structural abnormalities in human patients revealed overexpression of LIS1, a protein known to
impact neuronal migration, displayed aberrant migration and decreased expression of polarity
proteins, suggesting that these proteins play a role in maintaining cell polarity during earlier
stages of neurodevelopment (Bi, Sapir et al. 2009). In cerebellar radial glial cells, Par6 is
necessary for normal migration (Solecki, Model et al. 2004). Although it is unclear if these
polarity proteins play a similar role in migrating interneurons, they represent potential candidates
to investigate if inhibition of OXPHOS results in a true loss of polarity.
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One defining feature of interneuron polarity is the centrosome’s localization anterior to the
nucleus and within the leading process (Bellion, Baudoin et al. 2005). Indeed, in our experiments,
we saw abnormal localization of centrosomes in Ant1 -/- interneurons that was exacerbated with
additional inhibition of OXPHOS (Figure 11). The centriole associates closely with the primary
cilium in migrating interneurons (Baudoin, Viou et al. 2012, Higginbotham, Eom et al. 2012).
Conditional deletion of Arl13b in migrating interneurons results in erratic cell migration
behavior, with decreased progressive migration. Additionally, these mutants display abnormal
branches emerging from the rear of the cell similar to what we have characterized as extended
trailing processes (Higginbotham, Eom et al. 2012). These studies also displayed abnormal
responses to guidance cues, emphasizing a potential for a multifactorial mechanism leading to the
abnormal migration observed in our studies.
Guidance Factors
Another possible mechanism for the reduced progressive interneuron migration following
mitochondrial manipulations is abnormal responsiveness to guidance signals. As discussed above,
it may be a contributing factor if mitochondrial manipulations interfere with the maintenance and
function of the primary cilium. Additionally, the leading process itself plays a central role in
directing oriented migration of interneurons in response to guidance cues (Martini, Valiente et al.
2009). Thus, we are presented with the possibility that abnormal leading process dynamics reduce
the structural capacity of migrating interneurons to respond to directional cues properly or
potential defects in primary cilium function result in the output of increased direction changes and
impacts on polarity.
In our work, we did not address the effect of inhibition of oxidative phosphorylation on the
ability of interneurons to respond to external cues. Although the spatiotemporal landscape of
82

guidance cues for interneurons in vivo is full of contextual variability and the responsible
receptors and downstream effectors have not been conclusively defined, several guidance cue
candidates have displayed motogenic, repulsive, and attractive cues to interneurons in explant
culture. Slits, a secreted signaling molecule expressed in the MGE and LGE are thought to repel
interneurons from the proliferative zones towards the dorsal pallium (Zhu, Li et al. 1999). When
exposed to a source of Slit in culture, interneurons display a robust directional response.
Semaphorins 3A and 3F expressed in the striatum are also known to repel MGE interneurons
(Marin, Yaron et al. 2001). Nrg1-IG, a diffusible splice variant of neuregulin has been shown to
be a robust attractant in vitro (Martini, Valiente et al. 2009). Each of these secreted molecules are
potential candidates to investigate the ability of interneurons to respond to extracellular cues
under the challenge of oxidative phosphorylation inhibition in vitro.
In addition to attractive and repulsive cues, there are a series of secreted factors in the ventral
pallium that serve as pro-motogenic factors. Scatter factor (SF) and BDNF are expressed in the
MGE (Powell, Mars et al. 2001). In the context of our explant model, these factors should be
present, although it is possible the production and secretion of these molecules are impeded by
OXPHOS inhibition. Providing these factors at high concentrations with substrates such as beads
or with concentration gradients in microfluidic chambers may allow for a categorical assessment
of the cells ability respond to external cues in an OXPHOS inhibition model (Higginbotham, Eom
et al. 2012).
Additional roles of mitochondria in neuronal physiology
We have shown that the mitochondrial energetics are important for normal neuronal
migration. Mitochondria have multiple roles within neurons in addition to acting energy
production, including calcium buffering (Kwon, Sando et al. 2016), steroid hormone synthesis
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(Osheroff and Hatten 2009), regulation of reactive oxygen species (Hou, Ouyang et al. 2012),
apoptosis, and fatty acid synthesis (Kastaniotis, Autio et al. 2016). Each of these areas present
avenues of inquiry for the potential complex and interconnected regulation of neurodevelopment.
For the purpose of this discussion, we have focused on the role of mitochondria in calcium
homeostasis.
Calcium oscillations have been observed in migrating interneurons and are required for
normal interneuron migration (Bortone and Polleux 2009, Martini and Valdeolmillos 2010).
These oscillations have been linked to GABAA receptor depolarization and from Ca2+ release
from the endoplasmic reticulum. Abolishing calcium transients during migration by chelation
with BAPTA decreases actin condensations in the trailing process, and reduces myosin IIB
phosphorylation (Martini and Valdeolmillos 2010). Manipulation of the potassium-chloride
cotransporter, KCC2, directly impacts the frequency of calcium oscillations: high KCC2
abrogates calcium oscillations and results in increased pausing of interneurons (Bortone and
Polleux 2009).
MCU, the calcium uniporter localized within mitochondria allows for a rapid uptake of
calcium. Further, mitochondria can closely associate with the endoplasmic reticulum to facilitate
this process. Interestingly, calcium oscillations have been shown in multiple cell types to support
oxidative phosphorylation, as oscillations promote the activation of proteins and generation of
substrates required for oxidative phosphorylation (Rizzuto, De Stefani et al. 2012). MCU function
is necessary for normal oxidative phosphorylation (Griffiths and Rutter 2009, Mallilankaraman,
Cardenas et al. 2015). It is possible that calcium oscillations during the early stages of interneuron
migration support the energetic demand during tangential migration, and that this need decreases
as interneurons shift towards their final destinations. In addition to determining if interfering with
calcium oscillatory behavior interferes with mitochondrial localization, it would also be
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fascinating to assess if interneurons expressing higher levels of KCC2 are less sensitive to
perturbations in oxidative phosphorylation.
Mitochondrial localization and dynamics
We found that mitochondria display specific subcellular localization that differs between the
dynamic localization in tangentially migrating interneurons and the static localization within
radially migrating pyramidal neurons. We then sought to determine if manipulations in
mitochondrial trafficking without interfering with mitochondrial function would be sufficient to
disrupt interneuron migration.
Although we were unable to confirm whether mitochondrial mislocalization causes abnormal
interneuron migration, there are examples of proteins known to interfere with interneuron
migration that also describe abnormal localization of mitochondria (Yamada, Yoshida et al. 2009,
Steinecke, Gampe et al. 2014, Norkett, Modi et al. 2016). It is unclear if the described
mitochondrial mislocalization contributes to abnormal migration phenotypes in these genetic
models. As discussed in Chapter 3, there are alternative reagents to test our hypothesis that the
subcellular localization of mitochondria is required for normal interneuron migration, particularly
in maintenance of interneuron polarity and trailing process contraction.
In addition to their trafficking behaviors, mitochondria undergo extensive fusion and
fission. Multiple proteins involved in fusion and fission have been implicated in cell migration in
the immune system and models of cancer cell migration (Campello, Lacalle et al. 2006, Desai,
Bhatia et al. 2013, Zhao, Zhang et al. 2013). Thus, it is possible that these proteins play a role in
the migration of neuronal cell types. There are currently studies in the literature examining
mitochondrial fusion and fission in migrating neurons. Before manipulation of these proteins is
pursued, fusion and fission of mitochondria within migrating interneurons should be assessed.
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Mitochondrially targeted photoactivatable-GFP co-expressed with MitoDsRed has been shown to
allow for tracking of mitochondrial fusion and fission in mammalian cells in culture (Karbowski,
Cleland et al. 2014). If such technically demanding imaging experiments prove unfeasible, the
overexpression and knockdown of these proteins are associated with abnormal mitochondrial
morphology, and thus may still provide adequate insight into the necessity of mitochondrial
fusion and fission during interneuron migration.
Overall, a primary function of the fusion and fission of mitochondria is to maintain
mitochondrial homeostasis. Impaired mitochondria are flagged by PINK, which facilitates parkin
recruitment and subsequent mitophagy (Vives-Bauza, Zhou et al. 2010). The majority of research
of PINK and parkin have been focused on their role in neurodegeneration. However, recent
studies suggest that mutations in these proteins result in embryonic changes in neuronal
physiology (Villeneuve, Purnell et al. 2016). It would be interesting to explore the role and
importance of mitophagy in migrating interneurons. There are new tools available that allow realtime monitoring of mitophagy, a key component to evaluating processes during active
interneuron migration. This consists of a tandem RFP-eGFP mitochondrially targeted protein. As
RFP is more pH stable, mitochondria targeted to lysosomes become marked in red (Kim, Khan et
al. 2013). Utilizing this tool in migrating interneurons and pyramidal neurons may reveal
differences in mitochondrial turnover between these populations. If interneurons have less
mitochondrial turnover, this may explain their increased sensitivity to mitochondrial
perturbations.
The significance of mixed mitochondrial populations
Our understanding of the complexity and heterogeneous nature of mitochondrial
populations is evolving. The first evidence that mitochondria are not a uniform population was
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the discovery that populations of mitochondria exist in differing stages of membrane polarity
(Smiley, Reers et al. 1991, Keil, Funke et al. 2011). This theoretically divides mitochondria into
more energetic populations with higher membrane polarity from those that are less so.
Interestingly, studies examining mitochondrial membrane potential at the early stages of the
developing blastocysts exhibit cell-type specific mitochondrial polarity (Van Blerkom, Cox et al.
2006). Some theorize that the variations in populations of mitochondria are linked with their age
and robustness. Lower energy producing mitochondria are thought to be older, and more likely to
undergo mitophagy (Jin, Lazarou et al. 2010, Hu, Li et al. 2016). This brings forth the question of
whether mitochondria within migrating interneurons and pyramidal neurons are a uniform or
mixed population. Utilizing indicators of mitochondrial membrane potential in migrating neurons
may reveal differences in the “activity” between these two cell types, or even between
mitochondria that localize to particular regions (Smiley, Reers et al. 1991, Keil, Funke et al.
2011). This has brought up fascinating concepts regarding variation in mitochondrial populations
and disease models. Cancerous cells are distinguishable from healthier cells by differences in
mitochondrial polarization in their populations (Jiang, Fan et al. 2015). Examining these features
of mitochondria in cell types with differing metabolic profiles and the potential for dysfunction in
disease is likely to be an exciting field of research with implications in neuronal development and
disease.
The role of mitochondria in radially migrating neurons
In our initial studies, we saw grossly fixed mitochondrial localization in radially migrating
pyramidal neurons (Figure 3). Initial experiments utilizing pharmacological inhibition of
OXPHOS with bongkrekic acid in whole brain slices showed normal radial migration rates as
compared to non-radially migrating interneurons. This was also seen at early stages (E18.5) in
Ant1-/- embryos (Figure10). However, we observed a subtle effect on radial migration with
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expression of Miro1K208 at postnatal stages after migration should be complete (P15) (Figure
19). Investigating Ant1-/- pyramidal neurons electroporated with GFP at these later time points
would give an indication if deficits in OXPHOS utilization also result in similar, or more severe
migration deficits.
This data also brings forth the question of what impacts we may see on pyramidal neuron
development with more severe inhibition of mitochondrial function and localization. Within the
literature, there are three examples of abnormal radial migration being associated with
mitochondrial localization. Knockdown of Pdss2, a protein involved in ubiquinone biosynthesis,
results in morphologically abnormal mitochondria and significant impingements on radial
migration paired with more severe impacts including reduced cell proliferation and increased cell
death (Lu, Lu et al. 2012). As with other studies, it is unclear what component of mitochondrial
physiology is impacted, thus it is difficult to place this mutation on a scale of mitochondrial
deficits. Ubiquitination is an important component of the regulation mitochondrial fission; thus, it
is possible that loss of this protein impedes normal mitochondrial homeostasis. Overexpression of
mitochondria-localized glutamic acid-rich protein (MGARP) resulted in a combination of
mitochondrial defects including abnormal structure, distribution and mitochondrial motility (Jia,
Liang et al. 2014). This subsequently resulted in radial migration deficits. Although
mitochondrial function was not assessed in this model, these studies present evidence for later
developmental abnormalities in the reduced dendrite and axon formation in cultured neurons with
MGARP overexpression, and the reverse with knockdown of MGARP. This emphasizes two
intriguing concepts; the potential for additive developmental impacts of chronic/progressive
mitochondrial dysfunction, and the potential importance of the appropriate balance of
mitochondrial proteins and their functions.
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Knockdown of TAU, a microtubule stabilizing protein, induces deficits in mitochondrial
localization, radial migration, and dendritic arborization (Sapir, Frotscher et al. 2012). Although
further studies are required to both characterize and determine the contribution of mitochondrial
dysfunction to the phenotype, it would be interesting to utilize this genetic model to test
pharmacological interventions that boost mitochondrial function. As TAU microdeletions are
associated with neurological disease in humans, positive results from such studies would provide
a foundation for potential therapeutic interventions.
These data from the literature and our subtle migration phenotype observed in radially
migrating neurons suggests that there are certain components of radial migration that may be
altered with mitochondrial disruption, potentially more severely compared to the manipulations
we made in our evaluation of oxidative phosphorylation. The subtle impacts we observed with
overexpression of M1K208 in PN cells indicated that effects of less severe mitochondrial
manipulations may have impacts later on in the radial migration process. Additionally,
mitochondrial proteins have been shown to play a role in proliferation and differentiation (Kim,
Shaker et al. 2015), and cell orientation in dividing neuronal stem cells (Mattson and Partin
1999). Thus, there are likely time-dependent requirements for mitochondrial functions such as
OXPHOS during radial neuron development, and the severity of pathology is dependent on when
these impacts occur during pyramidal neuron development.
Preliminary data utilizing an Emx-Cre conditional deletion of Ant2 on an Ant1 background
suggests that cortical development can be profoundly impacted with more drastic interference of
OXPHOS. At E18.5, Ant2fl/yAnt1-/-Emx-Cre+ mice have significantly smaller cortices, and
expanded cortical ventricular zones (Figure 21). Although preliminary data does not suggest
significant differences in proliferation or cell death within the cortex, more individuals are
required to do a quantitative comparison. The fact that few GFP electroporated cells at e14.5
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emerged from this expanded ventricular zone after 4 days puts for the possibility that these cells
have deficits in initiating radial migration or invading the cortical plate. Small numbers of
electroporated cells can be seen outside the expanded ventricular zone with abnormally structured
and oriented processes (Figure 21D, 21F). This preliminary data suggests that there is a threshold
level of OXPHOS function, below which pyramidal neuronal development becomes
compromised.
Implications for neurological diseases
Our work emphasizes the importance of exploring the importance of mitochondria at various
stages of neurodevelopment. In our studies, we could observe a gradient of impacts; interfering
with mitochondrial trafficking with Miro1 did not impact migration rates, but interfering with
OXPHOS resulted in more severe phenotypes. Additionally, Ant1 interneurons were
hypersensitive to additional inhibition with BA, which likely was due to complete blocking of
ATP translocation through inhibition of Ant2. We also see this gradient of effect in the
development of pyramidal cells; a population that was only subtly impacted with mitochondrial
manipulations during migration becomes profoundly disrupted with ablation of both Ant1 and
Ant2. This gradient of impact presents us with a potential for “additive” injury. If the embryo is
exposed to additional stressors during stages of interneuron migration, it is possible those with
mitochondrial mutations may be more susceptible to developing interneuron-specific deficits. For
example, impaired mitochondrial function may increase risk of severe disruption of interneuron
migration due to oxygen deprivation.
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Figure 21. Preliminary data reveals profound cortical abnormalities in Ant1/2 DKO within
the mouse cortex.
(A) Conditional ablation of Ant2 in cortical pyramidal cells utilizing Emx-Cre on an Ant1 -/background results in grossly smaller telencephalon. (B) Inverted LUT of DAPI stained cross
sections of a DKO and Ant1+/- Ant2 null reveal that 1 copy of Ant1 is sufficient for visually
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normal cortical structure compared to severely abnormal cortex of DKO, characterized by an
expanded ventricular zone. (C, E) Ki67 and caspase 3 staining appears to be similar, suggesting
proliferation and cell death at E18.5 may be unaffected (more individuals required). (D) GFP
electroporated cells reveals few cells migrating outwards beyond the expanded ventricular zone.
(F) Inverted LUT images of cells from sections shown in (D) show the normal tapered apical
dendrite within cells that have reached the upper cortex in Het, while cells in the upper cortex of
DKO display abnormal arborization (red arrows, upper right panels), membrane blebbing (green
arrow, upper left panel). Cells in the lower cortex show mostly uniform orientation, while DKO
cells have putative leading processes oriented in multiple directions (black arrows, lower right
panels). N=2 Ant1+/-Ant2-/- females, 1 DKO. Scale bar = B: 250 µm, C-E: 50 µm, F: 25 µm.
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It would be interesting to utilize the Ant1-/- mouse model to test this theory of initial
mitochondrial mutations causing increased sensitivity to additional impingements. Interneuron
explants can be exposed to hypoxic culture conditions, and the impact to neuronal migration
assessed. Although more challenging, it is possible to model intrauterine growth restriction in
mice in by uterine artery ligation to reduce oxygenation of embryos. This method could be
utilized to subject Ant1-/- embryos to hypoxic conditions in vivo (Janot, Cortes-Dubly et al. 2014).
Another model of developmental impingements that can result in neuronal deficits include
viral infection and inflammation during gestation. Interest is growing in examining the impact of
viral infection and inflammation on mitochondria function (Anand 2013, Khan, Syed et al. 2015).
These are additional potential areas where combinatorial impingements could result in a gradient
of severity of interneuron developmental deficits.
Further exploration of varying levels of mitochondrial functional inhibition at different stages
of development may help elucidate if there are important developmental windows where
interneuron development can be compromised. One clear future study for our work would be to
examine interneuron development of Ant1-/- interneurons at later stages in development. It is
unclear if these cells will “catch up,” and reach their final destinations in time to form appropriate
synaptic connections. Additionally, the terminal differentiation and firing properties of Ant1 -/interneurons at postnatal stages should be addressed.
In summary, this work has opened a new arena of research in the field of neuronal migration.
As detailed above, our current lines of research could expand into investigations of the molecular
mechanisms of the unique phenotypes described in our experimental models, particularly
phenotypes involving cytoskeletal dynamics and cell polarity. Additionally, studies examining
non-OXPHOS-related functions of mitochondria are likely to provide additional insights into the
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roles and requirements of these versatile organelles during neurodevelopment. Further,
assessment of the effects of mitochondrial manipulations to both interneuron and pyramidal cells
at time points both preceding - and following - neuronal migration could pinpoint key windows in
which disruptions to mitochondrial function could precipitate pathologic outcomes during neural
development. In conclusion, a comprehensive understanding of mitochondrial contribution to
neurodevelopment as a whole is likely to not only to expand our basic understanding of the
nervous system, but also to lend insight into possible mechanisms behind and therapeutic avenues
towards the treatment of neurodevelopmental diseases.
Materials and methods
Mice
Ant2fl/flAnt1-/- and Ant1-/- mice were kindly provided by Dr. Doug Wallace. Ant1 mice
were bred with Emx-Cre mice to generate Ant1+/-EmxCre+ males. Ant1+/-EmxCre+ males were
bred with Ant2fl/flAnt1-/- females, and the resulting litters were used for experiments.
All mice were maintained on a C57/BL6 background The Institutional Animal Care and Use
Committee at the Children’s Hospital of Philadelphia, Philadelphia, PA, approved all studies.
In utero electroporation
Ant1/2-Emx-Cre litters were electroporated with pCAG-IG as previously described at
E14.5 and harvested at E18.5.
Immunohistochemistry
Brains from Ant1/2 –Emx-Cre litters were harvested and fixed as previously described
(materials and methods, Chapter 2). 50 micron floating sections were obtained utilizing a
94

vibratome, and slices were stained with caspase-3 (rabbit; Abcam, 1:500), Ki67 (rabbit;
Neomarkers, 1:300), or anti-GFP (chicken: Invitrogen, 1:2000). Secondary antibodies included
anti-rabbit-Alexa 594; Invitrogen anti-chick-Alexa 488; Invitrogen all at 1:2000. Nuclei were
counterstained with DAPI.
Immunocytochemistry
MGE explants were generated, cultured as previously described (materials and methods,
Chapter 2). Tubulin was labeled with anti-Tuj1 (rabbit; Neuronal CIII b-tubulin; Covance,
1:1000), or YL1/2 (Tyr-a-tubulin, Millipore; 1:750), and actin was labeled with Alexa Fluor 594
phalloidin (Molecular Probes; according to manufacturer’s instructions)
Microscopy
In vitro cultured MGE neurons were imaged utilizing a Leica CTR600 fluorescent
microscope. Imaging of Ant1/2 brain slices
Quantification

The expression of acetylated tubulin along the leading process of stained interneurons
were measured, as well as the total length of the leading process. The expression of acetylated
tubulin was evaluated as a percentage of total leading process length for each measured cell.
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